id	sid	tid	token	lemma	pos
ecj-9105	1	1	hrev_master	hrev_master	NOUN
ecj-9105	1	2	abstract	abstract	NOUN
ecj-9105	1	3	the	the	DET
ecj-9105	1	4	outbreak	outbreak	NOUN
ecj-9105	1	5	of	of	ADP
ecj-9105	1	6	coronavirus	coronavirus	NOUN
ecj-9105	1	7	disease	disease	NOUN
ecj-9105	1	8	2019	2019	NUM
ecj-9105	1	9	caused	cause	VERB
ecj-9105	1	10	by	by	ADP
ecj-9105	1	11	severe	severe	ADJ
ecj-9105	1	12	acute	acute	ADJ
ecj-9105	1	13	respiratory	respiratory	ADJ
ecj-9105	1	14	syndrome	syndrome	NOUN
ecj-9105	1	15	coronavirus	coronavirus	NOUN
ecj-9105	1	16	2	2	NUM
ecj-9105	1	17	is	be	AUX
ecj-9105	1	18	a	a	DET
ecj-9105	1	19	reason	reason	NOUN
ecj-9105	1	20	of	of	ADP
ecj-9105	1	21	concern	concern	NOUN
ecj-9105	1	22	worldwide	worldwide	ADV
ecj-9105	1	23	.	.	PUNCT
ecj-9105	2	1	while	while	SCONJ
ecj-9105	2	2	a	a	DET
ecj-9105	2	3	high	high	ADJ
ecj-9105	2	4	proportion	proportion	NOUN
ecj-9105	2	5	of	of	ADP
ecj-9105	2	6	adult	adult	NOUN
ecj-9105	2	7	patients	patient	NOUN
ecj-9105	2	8	have	have	AUX
ecj-9105	2	9	been	be	AUX
ecj-9105	2	10	severely	severely	ADV
ecj-9105	2	11	ill	ill	ADJ
ecj-9105	2	12	,	,	PUNCT
ecj-9105	2	13	requiring	require	VERB
ecj-9105	2	14	intensive	intensive	ADJ
ecj-9105	2	15	care	care	NOUN
ecj-9105	2	16	assistance	assistance	NOUN
ecj-9105	2	17	and	and	CCONJ
ecj-9105	2	18	mechanical	mechanical	ADJ
ecj-9105	2	19	ventilation	ventilation	NOUN
ecj-9105	2	20	,	,	PUNCT
ecj-9105	2	21	pediatric	pediatric	ADJ
ecj-9105	2	22	patients	patient	NOUN
ecj-9105	2	23	seem	seem	VERB
ecj-9105	2	24	to	to	PART
ecj-9105	2	25	have	have	VERB
ecj-9105	2	26	a	a	DET
ecj-9105	2	27	less	less	ADV
ecj-9105	2	28	invasive	invasive	ADJ
ecj-9105	2	29	clinical	clinical	ADJ
ecj-9105	2	30	expression	expression	NOUN
ecj-9105	2	31	of	of	ADP
ecj-9105	2	32	the	the	DET
ecj-9105	2	33	disease	disease	NOUN
ecj-9105	2	34	.	.	PUNCT
ecj-9105	3	1	reasons	reason	NOUN
ecj-9105	3	2	for	for	ADP
ecj-9105	3	3	a	a	DET
ecj-9105	3	4	milder	mild	ADJ
ecj-9105	3	5	disease	disease	NOUN
ecj-9105	3	6	in	in	ADP
ecj-9105	3	7	children	child	NOUN
ecj-9105	3	8	compared	compare	VERB
ecj-9105	3	9	to	to	ADP
ecj-9105	3	10	that	that	PRON
ecj-9105	3	11	seen	see	VERB
ecj-9105	3	12	in	in	ADP
ecj-9105	3	13	adults	adult	NOUN
ecj-9105	3	14	are	be	AUX
ecj-9105	3	15	yet	yet	ADV
ecj-9105	3	16	to	to	PART
ecj-9105	3	17	be	be	AUX
ecj-9105	3	18	elucidated	elucidate	VERB
ecj-9105	3	19	.	.	PUNCT
ecj-9105	4	1	nonetheless	nonetheless	ADV
ecj-9105	4	2	,	,	PUNCT
ecj-9105	4	3	severe	severe	ADJ
ecj-9105	4	4	and	and	CCONJ
ecj-9105	4	5	fatal	fatal	ADJ
ecj-9105	4	6	cases	case	NOUN
ecj-9105	4	7	have	have	AUX
ecj-9105	4	8	been	be	AUX
ecj-9105	4	9	reported	report	VERB
ecj-9105	4	10	in	in	ADP
ecj-9105	4	11	children	child	NOUN
ecj-9105	4	12	and	and	CCONJ
ecj-9105	4	13	are	be	AUX
ecj-9105	4	14	expected	expect	VERB
ecj-9105	4	15	to	to	PART
ecj-9105	4	16	continue	continue	VERB
ecj-9105	4	17	to	to	PART
ecj-9105	4	18	increase	increase	VERB
ecj-9105	4	19	with	with	ADP
ecj-9105	4	20	the	the	DET
ecj-9105	4	21	growing	grow	VERB
ecj-9105	4	22	community	community	NOUN
ecj-9105	4	23	transmission	transmission	NOUN
ecj-9105	4	24	and	and	CCONJ
ecj-9105	4	25	overall	overall	ADJ
ecj-9105	4	26	current	current	ADJ
ecj-9105	4	27	disease	disease	NOUN
ecj-9105	4	28	prevalence	prevalence	NOUN
ecj-9105	4	29	.	.	PUNCT
ecj-9105	5	1	we	we	PRON
ecj-9105	5	2	report	report	VERB
ecj-9105	5	3	the	the	DET
ecj-9105	5	4	first	first	ADJ
ecj-9105	5	5	case	case	NOUN
ecj-9105	5	6	of	of	ADP
ecj-9105	5	7	an	an	DET
ecj-9105	5	8	infant	infant	NOUN
ecj-9105	5	9	with	with	ADP
ecj-9105	5	10	a	a	DET
ecj-9105	5	11	very	very	ADV
ecj-9105	5	12	mild	mild	ADJ
ecj-9105	5	13	not	not	PART
ecj-9105	5	14	-	-	PUNCT
ecj-9105	5	15	respiratory	respiratory	ADJ
ecj-9105	5	16	covid19	covid19	NOUN
ecj-9105	5	17	infection	infection	NOUN
ecj-9105	5	18	and	and	CCONJ
ecj-9105	5	19	a	a	DET
ecj-9105	5	20	concomitant	concomitant	NOUN
ecj-9105	5	21	invasive	invasive	ADJ
ecj-9105	5	22	bacterial	bacterial	ADJ
ecj-9105	5	23	sepsis	sepsis	NOUN
ecj-9105	5	24	.	.	PUNCT
ecj-9105	6	1	introduction	introduction	NOUN
ecj-9105	6	2	the	the	DET
ecj-9105	6	3	first	first	ADJ
ecj-9105	6	4	case	case	NOUN
ecj-9105	6	5	affected	affect	VERB
ecj-9105	6	6	by	by	ADP
ecj-9105	6	7	novel	novel	ADJ
ecj-9105	6	8	coronavirus	coronavirus	NOUN
ecj-9105	6	9	disease	disease	NOUN
ecj-9105	6	10	2019	2019	NUM
ecj-9105	6	11	(	(	PUNCT
ecj-9105	6	12	covid-19	covid-19	PROPN
ecj-9105	6	13	)	)	PUNCT
ecj-9105	6	14	in	in	ADP
ecj-9105	6	15	italian	italian	ADJ
ecj-9105	6	16	adult	adult	NOUN
ecj-9105	6	17	population	population	NOUN
ecj-9105	6	18	,	,	PUNCT
ecj-9105	6	19	has	have	AUX
ecj-9105	6	20	been	be	AUX
ecj-9105	6	21	diagnosed	diagnose	VERB
ecj-9105	6	22	on	on	ADP
ecj-9105	6	23	february	february	PROPN
ecj-9105	6	24	21	21	NUM
ecj-9105	6	25	,	,	PUNCT
ecj-9105	6	26	2020.1	2020.1	NUM
ecj-9105	6	27	the	the	DET
ecj-9105	6	28	worldwide	worldwide	ADJ
ecj-9105	6	29	first	first	ADJ
ecj-9105	6	30	pediatric	pediatric	ADJ
ecj-9105	6	31	case	case	NOUN
ecj-9105	6	32	of	of	ADP
ecj-9105	6	33	severe	severe	ADJ
ecj-9105	6	34	acute	acute	ADJ
ecj-9105	6	35	respiratory	respiratory	ADJ
ecj-9105	6	36	syndrome	syndrome	NOUN
ecj-9105	6	37	coronavirus	coronavirus	NOUN
ecj-9105	6	38	2	2	NUM
ecj-9105	6	39	(	(	PUNCT
ecj-9105	6	40	sars	sar	NOUN
ecj-9105	6	41	-	-	PUNCT
ecj-9105	6	42	cov-2	cov-2	NOUN
ecj-9105	6	43	)	)	PUNCT
ecj-9105	6	44	infection	infection	NOUN
ecj-9105	6	45	was	be	AUX
ecj-9105	6	46	detected	detect	VERB
ecj-9105	6	47	on	on	ADP
ecj-9105	6	48	january	january	PROPN
ecj-9105	6	49	26	26	NUM
ecj-9105	6	50	,	,	PUNCT
ecj-9105	6	51	2020	2020	NUM
ecj-9105	6	52	in	in	ADP
ecj-9105	6	53	china	china	PROPN
ecj-9105	6	54	xiaogan	xiaogan	PROPN
ecj-9105	6	55	,	,	PUNCT
ecj-9105	6	56	hubei	hubei	PROPN
ecj-9105	6	57	province.2	province.2	PROPN
ecj-9105	6	58	in	in	ADP
ecj-9105	6	59	pediatric	pediatric	ADJ
ecj-9105	6	60	population	population	NOUN
ecj-9105	6	61	,	,	PUNCT
ecj-9105	6	62	covid-19	covid-19	PROPN
ecj-9105	6	63	has	have	VERB
ecj-9105	6	64	usually	usually	ADV
ecj-9105	6	65	a	a	DET
ecj-9105	6	66	mild	mild	ADJ
ecj-9105	6	67	clinical	clinical	ADJ
ecj-9105	6	68	presentation	presentation	NOUN
ecj-9105	6	69	with	with	ADP
ecj-9105	6	70	heterogeneous	heterogeneous	ADJ
ecj-9105	6	71	and	and	CCONJ
ecj-9105	6	72	unspecific	unspecific	ADJ
ecj-9105	6	73	symptoms.3	symptoms.3	NOUN
ecj-9105	6	74	this	this	PRON
ecj-9105	6	75	in	in	ADP
ecj-9105	6	76	contrast	contrast	NOUN
ecj-9105	6	77	to	to	ADP
ecj-9105	6	78	the	the	DET
ecj-9105	6	79	high	high	ADJ
ecj-9105	6	80	susceptibility	susceptibility	NOUN
ecj-9105	6	81	of	of	ADP
ecj-9105	6	82	children	child	NOUN
ecj-9105	6	83	to	to	ADP
ecj-9105	6	84	some	some	DET
ecj-9105	6	85	potentially	potentially	ADV
ecj-9105	6	86	fatal	fatal	ADJ
ecj-9105	6	87	infectious	infectious	ADJ
ecj-9105	6	88	agents	agent	NOUN
ecj-9105	6	89	.	.	PUNCT
ecj-9105	7	1	lymphopenia	lymphopenia	NOUN
ecj-9105	7	2	is	be	AUX
ecj-9105	7	3	a	a	DET
ecj-9105	7	4	common	common	ADJ
ecj-9105	7	5	laboratory	laboratory	NOUN
ecj-9105	7	6	finding	finding	NOUN
ecj-9105	7	7	in	in	ADP
ecj-9105	7	8	sars	sar	NOUN
ecj-9105	7	9	-	-	PUNCT
ecj-9105	7	10	cov-2	cov-2	PART
ecj-9105	7	11	infection	infection	NOUN
ecj-9105	7	12	,	,	PUNCT
ecj-9105	7	13	mainly	mainly	ADV
ecj-9105	7	14	in	in	ADP
ecj-9105	7	15	severe	severe	ADJ
ecj-9105	7	16	cases.4	cases.4	PROPN
ecj-9105	7	17	in	in	ADP
ecj-9105	7	18	addition	addition	NOUN
ecj-9105	7	19	,	,	PUNCT
ecj-9105	7	20	it	it	PRON
ecj-9105	7	21	has	have	AUX
ecj-9105	7	22	been	be	AUX
ecj-9105	7	23	reported	report	VERB
ecj-9105	7	24	significantly	significantly	ADV
ecj-9105	7	25	lower	low	ADJ
ecj-9105	7	26	t	t	PROPN
ecj-9105	7	27	cells	cell	NOUN
ecj-9105	7	28	cd8	cd8	PROPN
ecj-9105	7	29	+	+	PROPN
ecj-9105	7	30	lymphocytes	lymphocyte	NOUN
ecj-9105	7	31	and	and	CCONJ
ecj-9105	7	32	natural	natural	ADJ
ecj-9105	7	33	killer	killer	NOUN
ecj-9105	7	34	(	(	PUNCT
ecj-9105	7	35	nk	nk	PROPN
ecj-9105	7	36	)	)	PUNCT
ecj-9105	7	37	cells	cell	NOUN
ecj-9105	7	38	in	in	ADP
ecj-9105	7	39	patients	patient	NOUN
ecj-9105	7	40	with	with	ADP
ecj-9105	7	41	severe	severe	ADJ
ecj-9105	7	42	clinical	clinical	ADJ
ecj-9105	7	43	course	course	NOUN
ecj-9105	7	44	compared	compare	VERB
ecj-9105	7	45	to	to	ADP
ecj-9105	7	46	those	those	PRON
ecj-9105	7	47	with	with	ADP
ecj-9105	7	48	mild	mild	ADJ
ecj-9105	7	49	infection	infection	NOUN
ecj-9105	7	50	and	and	CCONJ
ecj-9105	7	51	healthy	healthy	ADJ
ecj-9105	7	52	individuals.5	individuals.5	VERB
ecj-9105	7	53	these	these	DET
ecj-9105	7	54	impaired	impair	VERB
ecj-9105	7	55	virus	virus	NOUN
ecj-9105	7	56	-	-	PUNCT
ecj-9105	7	57	related	relate	VERB
ecj-9105	7	58	immunological	immunological	ADJ
ecj-9105	7	59	changes	change	NOUN
ecj-9105	7	60	might	might	AUX
ecj-9105	7	61	lead	lead	VERB
ecj-9105	7	62	to	to	ADP
ecj-9105	7	63	an	an	DET
ecj-9105	7	64	increased	increase	VERB
ecj-9105	7	65	susceptibility	susceptibility	NOUN
ecj-9105	7	66	to	to	ADP
ecj-9105	7	67	other	other	ADJ
ecj-9105	7	68	,	,	PUNCT
ecj-9105	7	69	mainly	mainly	ADV
ecj-9105	7	70	bacterial	bacterial	ADJ
ecj-9105	7	71	,	,	PUNCT
ecj-9105	7	72	agents	agent	NOUN
ecj-9105	7	73	in	in	ADP
ecj-9105	7	74	severely	severely	ADV
ecj-9105	7	75	affected	affect	VERB
ecj-9105	7	76	patients	patient	NOUN
ecj-9105	7	77	.	.	PUNCT
ecj-9105	8	1	we	we	PRON
ecj-9105	8	2	report	report	VERB
ecj-9105	8	3	the	the	DET
ecj-9105	8	4	first	first	ADJ
ecj-9105	8	5	case	case	NOUN
ecj-9105	8	6	of	of	ADP
ecj-9105	8	7	otherwise	otherwise	ADV
ecj-9105	8	8	healthy	healthy	ADJ
ecj-9105	8	9	infant	infant	NOUN
ecj-9105	8	10	with	with	ADP
ecj-9105	8	11	a	a	DET
ecj-9105	8	12	very	very	ADV
ecj-9105	8	13	mild	mild	ADJ
ecj-9105	8	14	covid-19	covid-19	PROPN
ecj-9105	8	15	infection	infection	NOUN
ecj-9105	8	16	and	and	CCONJ
ecj-9105	8	17	a	a	DET
ecj-9105	8	18	concomitant	concomitant	ADJ
ecj-9105	8	19	severe	severe	ADJ
ecj-9105	8	20	bacterial	bacterial	ADJ
ecj-9105	8	21	sepsis	sepsis	NOUN
ecj-9105	8	22	.	.	PUNCT
ecj-9105	9	1	case	case	NOUN
ecj-9105	9	2	presentation	presentation	NOUN
ecj-9105	9	3	a	a	DET
ecj-9105	9	4	9	9	NUM
ecj-9105	9	5	months	month	NOUN
ecj-9105	9	6	-	-	PUNCT
ecj-9105	9	7	old	old	ADJ
ecj-9105	9	8	otherwise	otherwise	ADV
ecj-9105	9	9	healthy	healthy	ADJ
ecj-9105	9	10	male	male	NOUN
ecj-9105	9	11	infant	infant	NOUN
ecj-9105	9	12	with	with	ADP
ecj-9105	9	13	a	a	DET
ecj-9105	9	14	6	6	NUM
ecj-9105	9	15	-	-	PUNCT
ecj-9105	9	16	day	day	NOUN
ecj-9105	9	17	history	history	NOUN
ecj-9105	9	18	of	of	ADP
ecj-9105	9	19	fever	fever	NOUN
ecj-9105	9	20	and	and	CCONJ
ecj-9105	9	21	diarrhea	diarrhea	NOUN
ecj-9105	9	22	,	,	PUNCT
ecj-9105	9	23	was	be	AUX
ecj-9105	9	24	brought	bring	VERB
ecj-9105	9	25	to	to	ADP
ecj-9105	9	26	the	the	DET
ecj-9105	9	27	pediatric	pediatric	ADJ
ecj-9105	9	28	emergency	emergency	NOUN
ecj-9105	9	29	unit	unit	NOUN
ecj-9105	9	30	of	of	ADP
ecj-9105	9	31	“	"	PUNCT
ecj-9105	9	32	santobono	santobono	NOUN
ecj-9105	9	33	-	-	PUNCT
ecj-9105	9	34	pausilipon	pausilipon	NOUN
ecj-9105	9	35	”	"	PUNCT
ecj-9105	9	36	children	child	NOUN
ecj-9105	9	37	’s	’s	PART
ecj-9105	9	38	hospital	hospital	NOUN
ecj-9105	9	39	.	.	PUNCT
ecj-9105	10	1	this	this	PRON
ecj-9105	10	2	is	be	AUX
ecj-9105	10	3	the	the	DET
ecj-9105	10	4	most	most	ADV
ecj-9105	10	5	important	important	ADJ
ecj-9105	10	6	pediatric	pediatric	ADJ
ecj-9105	10	7	hospital	hospital	NOUN
ecj-9105	10	8	of	of	ADP
ecj-9105	10	9	south	south	PROPN
ecj-9105	10	10	italy	italy	PROPN
ecj-9105	10	11	and	and	CCONJ
ecj-9105	10	12	here	here	ADV
ecj-9105	10	13	,	,	PUNCT
ecj-9105	10	14	many	many	ADJ
ecj-9105	10	15	patients	patient	NOUN
ecj-9105	10	16	are	be	AUX
ecj-9105	10	17	treated	treat	VERB
ecj-9105	10	18	and	and	CCONJ
ecj-9105	10	19	cared	care	VERB
ecj-9105	10	20	;	;	PUNCT
ecj-9105	10	21	about	about	ADV
ecj-9105	10	22	100.000	100.000	NUM
ecj-9105	10	23	patients	patient	NOUN
ecj-9105	10	24	under	under	ADP
ecj-9105	10	25	14	14	NUM
ecj-9105	10	26	years	year	NOUN
ecj-9105	10	27	access	access	NOUN
ecj-9105	10	28	each	each	DET
ecj-9105	10	29	year	year	NOUN
ecj-9105	10	30	to	to	ADP
ecj-9105	10	31	our	our	PRON
ecj-9105	10	32	pediatric	pediatric	ADJ
ecj-9105	10	33	emergency	emergency	NOUN
ecj-9105	10	34	unit	unit	NOUN
ecj-9105	10	35	.	.	PUNCT
ecj-9105	11	1	according	accord	VERB
ecj-9105	11	2	to	to	ADP
ecj-9105	11	3	world	world	PROPN
ecj-9105	11	4	health	health	NOUN
ecj-9105	11	5	organization	organization	NOUN
ecj-9105	11	6	(	(	PUNCT
ecj-9105	11	7	who	who	PRON
ecj-9105	11	8	)	)	PUNCT
ecj-9105	11	9	recommendations	recommendation	NOUN
ecj-9105	11	10	,	,	PUNCT
ecj-9105	11	11	during	during	ADP
ecj-9105	11	12	this	this	DET
ecj-9105	11	13	pandemic	pandemic	ADJ
ecj-9105	11	14	our	our	PRON
ecj-9105	11	15	hospital	hospital	NOUN
ecj-9105	11	16	ensures	ensure	VERB
ecj-9105	11	17	that	that	SCONJ
ecj-9105	11	18	covid-19	covid-19	PROPN
ecj-9105	11	19	patients	patient	NOUN
ecj-9105	11	20	can	can	AUX
ecj-9105	11	21	access	access	VERB
ecj-9105	11	22	life	life	NOUN
ecj-9105	11	23	-	-	PUNCT
ecj-9105	11	24	saving	save	VERB
ecj-9105	11	25	treatment	treatment	NOUN
ecj-9105	11	26	,	,	PUNCT
ecj-9105	11	27	without	without	ADP
ecj-9105	11	28	compromising	compromise	VERB
ecj-9105	11	29	public	public	ADJ
ecj-9105	11	30	health	health	NOUN
ecj-9105	11	31	objectives	objective	NOUN
ecj-9105	11	32	and	and	CCONJ
ecj-9105	11	33	safety	safety	NOUN
ecj-9105	11	34	of	of	ADP
ecj-9105	11	35	health	health	NOUN
ecj-9105	11	36	worker.6	worker.6	PROPN
ecj-9105	11	37	care	care	NOUN
ecj-9105	11	38	for	for	ADP
ecj-9105	11	39	all	all	PRON
ecj-9105	11	40	suspected	suspect	VERB
ecj-9105	11	41	and	and	CCONJ
ecj-9105	11	42	confirmed	confirm	VERB
ecj-9105	11	43	covid-19	covid-19	PROPN
ecj-9105	11	44	patients	patient	NOUN
ecj-9105	11	45	is	be	AUX
ecj-9105	11	46	provided	provide	VERB
ecj-9105	11	47	in	in	ADP
ecj-9105	11	48	the	the	DET
ecj-9105	11	49	designated	designate	VERB
ecj-9105	11	50	treatment	treatment	NOUN
ecj-9105	11	51	area	area	NOUN
ecj-9105	11	52	,	,	PUNCT
ecj-9105	11	53	according	accord	VERB
ecj-9105	11	54	to	to	ADP
ecj-9105	11	55	disease	disease	NOUN
ecj-9105	11	56	severity	severity	NOUN
ecj-9105	11	57	and	and	CCONJ
ecj-9105	11	58	acute	acute	NOUN
ecj-9105	11	59	care	care	NOUN
ecj-9105	11	60	needs	need	NOUN
ecj-9105	11	61	.	.	PUNCT
ecj-9105	12	1	the	the	DET
ecj-9105	12	2	studied	study	VERB
ecj-9105	12	3	infant	infant	NOUN
ecj-9105	12	4	had	have	VERB
ecj-9105	12	5	no	no	DET
ecj-9105	12	6	respiratory	respiratory	ADJ
ecj-9105	12	7	symptoms	symptom	NOUN
ecj-9105	12	8	.	.	PUNCT
ecj-9105	13	1	household	household	NOUN
ecj-9105	13	2	members	member	NOUN
ecj-9105	13	3	had	have	VERB
ecj-9105	13	4	a	a	DET
ecj-9105	13	5	history	history	NOUN
ecj-9105	13	6	of	of	ADP
ecj-9105	13	7	fever	fever	NOUN
ecj-9105	13	8	lasting	last	VERB
ecj-9105	13	9	10	10	NUM
ecj-9105	13	10	days	day	NOUN
ecj-9105	13	11	in	in	ADP
ecj-9105	13	12	the	the	DET
ecj-9105	13	13	last	last	ADJ
ecj-9105	13	14	month	month	NOUN
ecj-9105	13	15	.	.	PUNCT
ecj-9105	14	1	furthermore	furthermore	ADV
ecj-9105	14	2	,	,	PUNCT
ecj-9105	14	3	father	father	PROPN
ecj-9105	14	4	’s	’s	PART
ecj-9105	14	5	infant	infant	NOUN
ecj-9105	14	6	had	have	AUX
ecj-9105	14	7	travelled	travel	VERB
ecj-9105	14	8	to	to	ADP
ecj-9105	14	9	one	one	NUM
ecj-9105	14	10	of	of	ADP
ecj-9105	14	11	the	the	DET
ecj-9105	14	12	first	first	ADJ
ecj-9105	14	13	sarscov-2	sarscov-2	NUM
ecj-9105	14	14	quarantine	quarantine	NOUN
ecj-9105	14	15	areas	area	NOUN
ecj-9105	14	16	,	,	PUNCT
ecj-9105	14	17	set	set	VERB
ecj-9105	14	18	up	up	ADP
ecj-9105	14	19	in	in	ADP
ecj-9105	14	20	northern	northern	ADJ
ecj-9105	14	21	italy	italy	PROPN
ecj-9105	14	22	.	.	PUNCT
ecj-9105	15	1	no	no	DET
ecj-9105	15	2	other	other	ADJ
ecj-9105	15	3	ill	ill	ADJ
ecj-9105	15	4	contacts	contact	NOUN
ecj-9105	15	5	or	or	CCONJ
ecj-9105	15	6	known	know	VERB
ecj-9105	15	7	contacts	contact	NOUN
ecj-9105	15	8	with	with	ADP
ecj-9105	15	9	sars	sar	NOUN
ecj-9105	15	10	-	-	PUNCT
ecj-9105	15	11	cov-2	cov-2	PART
ecj-9105	15	12	infected	infected	ADJ
ecj-9105	15	13	subjects	subject	NOUN
ecj-9105	15	14	were	be	AUX
ecj-9105	15	15	reported	report	VERB
ecj-9105	15	16	.	.	PUNCT
ecj-9105	16	1	based	base	VERB
ecj-9105	16	2	on	on	ADP
ecj-9105	16	3	family	family	NOUN
ecj-9105	16	4	history	history	NOUN
ecj-9105	16	5	and	and	CCONJ
ecj-9105	16	6	on	on	ADP
ecj-9105	16	7	the	the	DET
ecj-9105	16	8	presence	presence	NOUN
ecj-9105	16	9	of	of	ADP
ecj-9105	16	10	fever	fever	NOUN
ecj-9105	16	11	,	,	PUNCT
ecj-9105	16	12	the	the	DET
ecj-9105	16	13	patient	patient	NOUN
ecj-9105	16	14	was	be	AUX
ecj-9105	16	15	considered	consider	VERB
ecj-9105	16	16	as	as	ADP
ecj-9105	16	17	a	a	DET
ecj-9105	16	18	suspected	suspect	VERB
ecj-9105	16	19	covid-19	covid-19	PROPN
ecj-9105	16	20	case	case	NOUN
ecj-9105	16	21	and	and	CCONJ
ecj-9105	16	22	was	be	AUX
ecj-9105	16	23	diverted	divert	VERB
ecj-9105	16	24	to	to	ADP
ecj-9105	16	25	the	the	DET
ecj-9105	16	26	designated	designate	VERB
ecj-9105	16	27	covid-19	covid-19	PROPN
ecj-9105	16	28	track	track	NOUN
ecj-9105	16	29	.	.	PUNCT
ecj-9105	17	1	on	on	ADP
ecj-9105	17	2	admission	admission	NOUN
ecj-9105	17	3	,	,	PUNCT
ecj-9105	17	4	the	the	DET
ecj-9105	17	5	infant	infant	NOUN
ecj-9105	17	6	had	have	VERB
ecj-9105	17	7	very	very	ADV
ecj-9105	17	8	poor	poor	ADJ
ecj-9105	17	9	general	general	ADJ
ecj-9105	17	10	condition	condition	NOUN
ecj-9105	17	11	and	and	CCONJ
ecj-9105	17	12	irritability	irritability	NOUN
ecj-9105	17	13	.	.	PUNCT
ecj-9105	18	1	the	the	DET
ecj-9105	18	2	state	state	NOUN
ecj-9105	18	3	of	of	ADP
ecj-9105	18	4	consciousness	consciousness	NOUN
ecj-9105	18	5	was	be	AUX
ecj-9105	18	6	normal	normal	ADJ
ecj-9105	18	7	.	.	PUNCT
ecj-9105	19	1	physical	physical	ADJ
ecj-9105	19	2	examination	examination	NOUN
ecj-9105	19	3	revealed	reveal	VERB
ecj-9105	19	4	a	a	DET
ecj-9105	19	5	body	body	NOUN
ecj-9105	19	6	temperature	temperature	NOUN
ecj-9105	19	7	of	of	ADP
ecj-9105	19	8	39.5	39.5	NUM
ecj-9105	19	9	°	°	NOUN
ecj-9105	19	10	c	c	NOUN
ecj-9105	19	11	,	,	PUNCT
ecj-9105	19	12	slight	slight	ADJ
ecj-9105	19	13	skin	skin	NOUN
ecj-9105	19	14	mottling	mottling	NOUN
ecj-9105	19	15	,	,	PUNCT
ecj-9105	19	16	mild	mild	ADJ
ecj-9105	19	17	dehydration	dehydration	NOUN
ecj-9105	19	18	(	(	PUNCT
ecj-9105	19	19	refill	refill	NOUN
ecj-9105	19	20	of	of	ADP
ecj-9105	19	21	3	3	NUM
ecj-9105	19	22	second	second	ADJ
ecj-9105	19	23	)	)	PUNCT
ecj-9105	19	24	,	,	PUNCT
ecj-9105	19	25	no	no	DET
ecj-9105	19	26	tachypnoea	tachypnoea	NOUN
ecj-9105	19	27	(	(	PUNCT
ecj-9105	19	28	respiratory	respiratory	ADJ
ecj-9105	19	29	rate	rate	NOUN
ecj-9105	19	30	was	be	AUX
ecj-9105	19	31	42	42	NUM
ecj-9105	19	32	breaths	breath	NOUN
ecj-9105	19	33	per	per	ADP
ecj-9105	19	34	minute	minute	NOUN
ecj-9105	19	35	)	)	PUNCT
ecj-9105	19	36	,	,	PUNCT
ecj-9105	19	37	oxygen	oxygen	NOUN
ecj-9105	19	38	saturation	saturation	NOUN
ecj-9105	19	39	of	of	ADP
ecj-9105	19	40	98	98	NUM
ecj-9105	19	41	%	%	NOUN
ecj-9105	19	42	on	on	ADP
ecj-9105	19	43	room	room	NOUN
ecj-9105	19	44	air	air	NOUN
ecj-9105	19	45	,	,	PUNCT
ecj-9105	19	46	clear	clear	ADJ
ecj-9105	19	47	lungs	lung	NOUN
ecj-9105	19	48	auscultation	auscultation	NOUN
ecj-9105	19	49	and	and	CCONJ
ecj-9105	19	50	slightly	slightly	ADV
ecj-9105	19	51	tender	tender	ADJ
ecj-9105	19	52	abdomen	abdoman	NOUN
ecj-9105	19	53	.	.	PUNCT
ecj-9105	20	1	according	accord	VERB
ecj-9105	20	2	to	to	ADP
ecj-9105	20	3	our	our	PRON
ecj-9105	20	4	standard	standard	ADJ
ecj-9105	20	5	protocol	protocol	NOUN
ecj-9105	20	6	of	of	ADP
ecj-9105	20	7	care	care	NOUN
ecj-9105	20	8	for	for	ADP
ecj-9105	20	9	covid-19	covid-19	PROPN
ecj-9105	20	10	,	,	PUNCT
ecj-9105	20	11	the	the	DET
ecj-9105	20	12	patient	patient	ADJ
ecj-9105	20	13	underwent	underwent	NOUN
ecj-9105	20	14	to	to	ADP
ecj-9105	20	15	blood	blood	NOUN
ecj-9105	20	16	and	and	CCONJ
ecj-9105	20	17	microbiological	microbiological	ADJ
ecj-9105	20	18	exams	exam	NOUN
ecj-9105	20	19	including	include	VERB
ecj-9105	20	20	blood	blood	NOUN
ecj-9105	20	21	specimens	specimen	NOUN
ecj-9105	20	22	for	for	ADP
ecj-9105	20	23	cultures	culture	NOUN
ecj-9105	20	24	and	and	CCONJ
ecj-9105	20	25	nasopharyngeal	nasopharyngeal	ADJ
ecj-9105	20	26	swab	swab	NOUN
ecj-9105	20	27	specimen	speciman	NOUN
ecj-9105	20	28	for	for	ADP
ecj-9105	20	29	2019	2019	NUM
ecj-9105	20	30	-	-	PUNCT
ecj-9105	20	31	ncov	ncov	ADV
ecj-9105	20	32	nucleic	nucleic	ADJ
ecj-9105	20	33	acid	acid	NOUN
ecj-9105	20	34	(	(	PUNCT
ecj-9105	20	35	by	by	ADP
ecj-9105	20	36	a	a	DET
ecj-9105	20	37	real	real	ADJ
ecj-9105	20	38	-	-	PUNCT
ecj-9105	20	39	time	time	NOUN
ecj-9105	20	40	reverse	reverse	NOUN
ecj-9105	20	41	-	-	PUNCT
ecj-9105	20	42	transcriptase	transcriptase	NOUN
ecj-9105	20	43	polymerase	polymerase	NOUN
ecj-9105	20	44	-	-	PUNCT
ecj-9105	20	45	chain	chain	NOUN
ecj-9105	20	46	-	-	PUNCT
ecj-9105	20	47	reaction	reaction	NOUN
ecj-9105	20	48	-rt	-rt	NOUN
ecj-9105	20	49	-	-	PUNCT
ecj-9105	20	50	pcrassay	pcrassay	NOUN
ecj-9105	20	51	)	)	PUNCT
ecj-9105	20	52	.	.	PUNCT
ecj-9105	21	1	laboratory	laboratory	NOUN
ecj-9105	21	2	results	result	NOUN
ecj-9105	21	3	are	be	AUX
ecj-9105	21	4	showed	show	VERB
ecj-9105	21	5	in	in	ADP
ecj-9105	21	6	table	table	NOUN
ecj-9105	21	7	1	1	NUM
ecj-9105	21	8	.	.	PUNCT
ecj-9105	22	1	we	we	PRON
ecj-9105	22	2	observed	observe	VERB
ecj-9105	22	3	a	a	DET
ecj-9105	22	4	severe	severe	ADJ
ecj-9105	22	5	decrease	decrease	NOUN
ecj-9105	22	6	of	of	ADP
ecj-9105	22	7	leukocytes	leukocyte	NOUN
ecj-9105	22	8	and	and	CCONJ
ecj-9105	22	9	neutrophils	neutrophil	NOUN
ecj-9105	22	10	and	and	CCONJ
ecj-9105	22	11	high	high	ADJ
ecj-9105	22	12	values	value	NOUN
ecj-9105	22	13	of	of	ADP
ecj-9105	22	14	inflammatory	inflammatory	ADJ
ecj-9105	22	15	markers	marker	NOUN
ecj-9105	22	16	.	.	PUNCT
ecj-9105	23	1	emergency	emergency	NOUN
ecj-9105	23	2	care	care	PROPN
ecj-9105	23	3	journal	journal	PROPN
ecj-9105	23	4	2020	2020	NUM
ecj-9105	23	5	;	;	PUNCT
ecj-9105	23	6	volume	volume	NOUN
ecj-9105	23	7	16:9105	16:9105	PROPN
ecj-9105	23	8	correspondence	correspondence	NOUN
ecj-9105	23	9	:	:	PUNCT
ecj-9105	23	10	zenzeri	zenzeri	PROPN
ecj-9105	23	11	letizia	letizia	PROPN
ecj-9105	23	12	,	,	PUNCT
ecj-9105	23	13	pediatric	pediatric	ADJ
ecj-9105	23	14	emergency	emergency	NOUN
ecj-9105	23	15	unit	unit	NOUN
ecj-9105	23	16	,	,	PUNCT
ecj-9105	23	17	aorn	aorn	ADJ
ecj-9105	23	18	santobono	santobono	NOUN
ecj-9105	23	19	-	-	PUNCT
ecj-9105	23	20	pausilipon	pausilipon	NOUN
ecj-9105	23	21	children	child	NOUN
ecj-9105	23	22	’s	’s	PART
ecj-9105	23	23	hospital	hospital	NOUN
ecj-9105	23	24	,	,	PUNCT
ecj-9105	23	25	via	via	ADP
ecj-9105	23	26	mario	mario	PROPN
ecj-9105	23	27	fiore	fiore	PROPN
ecj-9105	23	28	,	,	PUNCT
ecj-9105	23	29	6	6	NUM
ecj-9105	23	30	,	,	PUNCT
ecj-9105	23	31	naples	naples	PROPN
ecj-9105	23	32	,	,	PUNCT
ecj-9105	23	33	italy	italy	PROPN
ecj-9105	23	34	.	.	PUNCT
ecj-9105	24	1	tel	tel	PROPN
ecj-9105	24	2	.	.	PUNCT
ecj-9105	24	3	:	:	PUNCT
ecj-9105	25	1	+39.3293577778	+39.3293577778	NUM
ecj-9105	25	2	e	e	NOUN
ecj-9105	25	3	-	-	NOUN
ecj-9105	25	4	mail	mail	NOUN
ecj-9105	25	5	:	:	PUNCT
ecj-9105	25	6	zenzeriletizia@gmail.com	zenzeriletizia@gmail.com	X
ecj-9105	26	1	key	key	ADJ
ecj-9105	26	2	words	word	NOUN
ecj-9105	26	3	:	:	PUNCT
ecj-9105	26	4	covid-19	covid-19	PROPN
ecj-9105	26	5	;	;	PUNCT
ecj-9105	26	6	children	child	NOUN
ecj-9105	26	7	;	;	PUNCT
ecj-9105	26	8	sepsis	sepsis	NOUN
ecj-9105	26	9	;	;	PUNCT
ecj-9105	26	10	diarrhea	diarrhea	NOUN
ecj-9105	26	11	;	;	PUNCT
ecj-9105	26	12	fever	fever	NOUN
ecj-9105	26	13	.	.	PUNCT
ecj-9105	27	1	conflict	conflict	NOUN
ecj-9105	27	2	of	of	ADP
ecj-9105	27	3	interest	interest	NOUN
ecj-9105	27	4	:	:	PUNCT
ecj-9105	27	5	no	no	DET
ecj-9105	27	6	one	one	NOUN
ecj-9105	27	7	.	.	PUNCT
ecj-9105	28	1	this	this	DET
ecj-9105	28	2	work	work	NOUN
ecj-9105	28	3	was	be	AUX
ecj-9105	28	4	not	not	PART
ecj-9105	28	5	supported	support	VERB
ecj-9105	28	6	by	by	ADP
ecj-9105	28	7	any	any	DET
ecj-9105	28	8	grant	grant	NOUN
ecj-9105	28	9	.	.	PUNCT
ecj-9105	29	1	ethics	ethic	NOUN
ecj-9105	29	2	approval	approval	NOUN
ecj-9105	29	3	and	and	CCONJ
ecj-9105	29	4	consent	consent	NOUN
ecj-9105	29	5	to	to	PART
ecj-9105	29	6	participate	participate	VERB
ecj-9105	29	7	:	:	PUNCT
ecj-9105	29	8	the	the	DET
ecj-9105	29	9	manuscript	manuscript	NOUN
ecj-9105	29	10	does	do	AUX
ecj-9105	29	11	not	not	PART
ecj-9105	29	12	contain	contain	VERB
ecj-9105	29	13	any	any	DET
ecj-9105	29	14	elements	element	NOUN
ecj-9105	29	15	that	that	PRON
ecj-9105	29	16	would	would	AUX
ecj-9105	29	17	allow	allow	VERB
ecj-9105	29	18	the	the	DET
ecj-9105	29	19	recognition	recognition	NOUN
ecj-9105	29	20	of	of	ADP
ecj-9105	29	21	the	the	DET
ecj-9105	29	22	patient	patient	NOUN
ecj-9105	29	23	.	.	PUNCT
ecj-9105	30	1	received	receive	VERB
ecj-9105	30	2	for	for	ADP
ecj-9105	30	3	publication	publication	NOUN
ecj-9105	30	4	:	:	PUNCT
ecj-9105	30	5	13	13	NUM
ecj-9105	30	6	may	may	PROPN
ecj-9105	30	7	2020	2020	NUM
ecj-9105	30	8	.	.	PUNCT
ecj-9105	31	1	accepted	accept	VERB
ecj-9105	31	2	for	for	ADP
ecj-9105	31	3	publication	publication	NOUN
ecj-9105	31	4	:	:	PUNCT
ecj-9105	31	5	12	12	NUM
ecj-9105	31	6	november	november	NOUN
ecj-9105	31	7	2020	2020	NUM
ecj-9105	31	8	.	.	PUNCT
ecj-9105	32	1	this	this	DET
ecj-9105	32	2	work	work	NOUN
ecj-9105	32	3	is	be	AUX
ecj-9105	32	4	licensed	license	VERB
ecj-9105	32	5	under	under	ADP
ecj-9105	32	6	a	a	DET
ecj-9105	32	7	creative	creative	ADJ
ecj-9105	32	8	commons	common	NOUN
ecj-9105	32	9	attribution	attribution	NOUN
ecj-9105	32	10	4.0	4.0	NUM
ecj-9105	32	11	license	license	NOUN
ecj-9105	32	12	(	(	PUNCT
ecj-9105	32	13	by	by	ADP
ecj-9105	32	14	-	-	PUNCT
ecj-9105	32	15	nc	nc	PROPN
ecj-9105	32	16	4.0	4.0	NUM
ecj-9105	32	17	)	)	PUNCT
ecj-9105	32	18	.	.	PUNCT
ecj-9105	33	1	©	©	PROPN
ecj-9105	33	2	copyright	copyright	NOUN
ecj-9105	33	3	:	:	PUNCT
ecj-9105	33	4	the	the	DET
ecj-9105	33	5	author(s	author(s	PROPN
ecj-9105	33	6	)	)	PUNCT
ecj-9105	33	7	,	,	PUNCT
ecj-9105	33	8	2020	2020	NUM
ecj-9105	33	9	licensee	licensee	NOUN
ecj-9105	33	10	pagepress	pagepress	NOUN
ecj-9105	33	11	,	,	PUNCT
ecj-9105	33	12	italy	italy	PROPN
ecj-9105	33	13	emergency	emergency	PROPN
ecj-9105	33	14	care	care	PROPN
ecj-9105	33	15	journal	journal	PROPN
ecj-9105	33	16	2020	2020	NUM
ecj-9105	33	17	;	;	PUNCT
ecj-9105	33	18	16:9105	16:9105	NUM
ecj-9105	33	19	doi:10.4081	doi:10.4081	NOUN
ecj-9105	33	20	/	/	SYM
ecj-9105	33	21	ecj.2020.9105	ecj.2020.9105	PROPN
ecj-9105	34	1	[	[	X
ecj-9105	34	2	emergency	emergency	NOUN
ecj-9105	34	3	care	care	NOUN
ecj-9105	34	4	journal	journal	NOUN
ecj-9105	34	5	2020	2020	NUM
ecj-9105	34	6	;	;	PUNCT
ecj-9105	34	7	16:9105	16:9105	NUM
ecj-9105	34	8	]	]	PUNCT
ecj-9105	35	1	[	[	X
ecj-9105	35	2	page	page	NOUN
ecj-9105	35	3	155	155	NUM
ecj-9105	35	4	]	]	PUNCT
ecj-9105	35	5	immunodepression	immunodepression	NOUN
ecj-9105	35	6	covid-19	covid-19	PROPN
ecj-9105	35	7	-	-	PUNCT
ecj-9105	35	8	related	relate	VERB
ecj-9105	35	9	as	as	ADP
ecj-9105	35	10	a	a	DET
ecj-9105	35	11	promoting	promote	VERB
ecj-9105	35	12	factor	factor	NOUN
ecj-9105	35	13	for	for	ADP
ecj-9105	35	14	severe	severe	ADJ
ecj-9105	35	15	pseudomonas	pseudomona	NOUN
ecj-9105	35	16	sepsis	sepsis	NOUN
ecj-9105	35	17	in	in	ADP
ecj-9105	35	18	an	an	DET
ecj-9105	35	19	infant	infant	NOUN
ecj-9105	35	20	with	with	ADP
ecj-9105	35	21	not	not	PART
ecj-9105	35	22	respiratory	respiratory	ADJ
ecj-9105	35	23	symptoms	symptom	NOUN
ecj-9105	35	24	letizia	letizia	PROPN
ecj-9105	35	25	zenzeri,1	zenzeri,1	PROPN
ecj-9105	35	26	antonietta	antonietta	PROPN
ecj-9105	35	27	giannattasio,1	giannattasio,1	NOUN
ecj-9105	35	28	geremia	geremia	PROPN
ecj-9105	35	29	zito	zito	PROPN
ecj-9105	35	30	marinosci,2	marinosci,2	PROPN
ecj-9105	35	31	eduardo	eduardo	PROPN
ecj-9105	35	32	ponticiello,1	ponticiello,1	PROPN
ecj-9105	35	33	margherita	margherita	PROPN
ecj-9105	35	34	raffaella	raffaella	PROPN
ecj-9105	35	35	iodice,1	iodice,1	PROPN
ecj-9105	35	36	maria	maria	PROPN
ecj-9105	35	37	erennia	erennia	PROPN
ecj-9105	35	38	vitullo,2	vitullo,2	NOUN
ecj-9105	35	39	vincenzo	vincenzo	PROPN
ecj-9105	35	40	tipo1	tipo1	PROPN
ecj-9105	35	41	1pediatric	1pediatric	NUM
ecj-9105	35	42	emergency	emergency	NOUN
ecj-9105	35	43	unit	unit	NOUN
ecj-9105	35	44	,	,	PUNCT
ecj-9105	35	45	santobono	santobono	NOUN
ecj-9105	35	46	-	-	PUNCT
ecj-9105	35	47	pausilipon	pausilipon	NOUN
ecj-9105	35	48	children	child	NOUN
ecj-9105	35	49	’s	’s	PART
ecj-9105	35	50	hospital	hospital	NOUN
ecj-9105	35	51	;	;	PUNCT
ecj-9105	35	52	2pediatric	2pediatric	NUM
ecj-9105	35	53	intensive	intensive	ADJ
ecj-9105	35	54	care	care	NOUN
ecj-9105	35	55	unit	unit	NOUN
ecj-9105	35	56	,	,	PUNCT
ecj-9105	35	57	santobono	santobono	NOUN
ecj-9105	35	58	-	-	PUNCT
ecj-9105	35	59	pausilipon	pausilipon	NOUN
ecj-9105	35	60	children	child	NOUN
ecj-9105	35	61	’s	’s	PART
ecj-9105	35	62	hospital	hospital	NOUN
ecj-9105	35	63	,	,	PUNCT
ecj-9105	35	64	naples	naples	PROPN
ecj-9105	35	65	,	,	PUNCT
ecj-9105	35	66	italy	italy	PROPN
ecj-9105	35	67	non	non	PROPN
ecj-9105	35	68	-co	-co	PROPN
ecj-9105	35	69	mmerc	mmerc	PROPN
ecj-9105	35	70	ial	ial	PROPN
ecj-9105	35	71	us	us	PROPN
ecj-9105	35	72	e	e	NOUN
ecj-9105	35	73	o	o	NOUN
ecj-9105	35	74	nly	nly	ADV
ecj-9105	35	75	infant	infant	PROPN
ecj-9105	35	76	’s	’s	PART
ecj-9105	35	77	serology	serology	NOUN
ecj-9105	35	78	revealed	reveal	VERB
ecj-9105	35	79	the	the	DET
ecj-9105	35	80	presence	presence	NOUN
ecj-9105	35	81	of	of	ADP
ecj-9105	35	82	igm	igm	PROPN
ecj-9105	35	83	and	and	CCONJ
ecj-9105	35	84	igg	igg	PROPN
ecj-9105	35	85	for	for	ADP
ecj-9105	35	86	covid19	covid19	NOUN
ecj-9105	35	87	infection	infection	NOUN
ecj-9105	35	88	,	,	PUNCT
ecj-9105	35	89	while	while	SCONJ
ecj-9105	35	90	mother	mother	NOUN
ecj-9105	35	91	’s	’s	PART
ecj-9105	35	92	serology	serology	NOUN
ecj-9105	35	93	(	(	PUNCT
ecj-9105	35	94	both	both	CCONJ
ecj-9105	35	95	igm	igm	PROPN
ecj-9105	35	96	and	and	CCONJ
ecj-9105	35	97	igg	igg	PROPN
ecj-9105	35	98	)	)	PUNCT
ecj-9105	35	99	was	be	AUX
ecj-9105	35	100	negative	negative	ADJ
ecj-9105	35	101	.	.	PUNCT
ecj-9105	36	1	covid-19	covid-19	PROPN
ecj-9105	36	2	was	be	AUX
ecj-9105	36	3	confirmed	confirm	VERB
ecj-9105	36	4	by	by	ADP
ecj-9105	36	5	rt	rt	PROPN
ecj-9105	36	6	-	-	PUNCT
ecj-9105	36	7	pcr	pcr	PROPN
ecj-9105	36	8	on	on	ADP
ecj-9105	36	9	nasopharyngeal	nasopharyngeal	ADJ
ecj-9105	36	10	swab	swab	NOUN
ecj-9105	36	11	specimen	speciman	NOUN
ecj-9105	36	12	.	.	PUNCT
ecj-9105	37	1	chest	chest	NOUN
ecj-9105	37	2	x	x	NOUN
ecj-9105	37	3	-	-	NOUN
ecj-9105	37	4	ray	ray	NOUN
ecj-9105	37	5	revealed	reveal	VERB
ecj-9105	37	6	no	no	DET
ecj-9105	37	7	pathologic	pathologic	ADJ
ecj-9105	37	8	findings	finding	NOUN
ecj-9105	37	9	.	.	PUNCT
ecj-9105	38	1	considering	consider	VERB
ecj-9105	38	2	the	the	DET
ecj-9105	38	3	compromised	compromise	VERB
ecj-9105	38	4	general	general	ADJ
ecj-9105	38	5	conditions	condition	NOUN
ecj-9105	38	6	and	and	CCONJ
ecj-9105	38	7	laboratory	laboratory	NOUN
ecj-9105	38	8	results	result	NOUN
ecj-9105	38	9	,	,	PUNCT
ecj-9105	38	10	our	our	PRON
ecj-9105	38	11	infant	infant	NOUN
ecj-9105	38	12	also	also	ADV
ecj-9105	38	13	underwent	undergo	VERB
ecj-9105	38	14	diagnostic	diagnostic	ADJ
ecj-9105	38	15	evaluation	evaluation	NOUN
ecj-9105	38	16	for	for	ADP
ecj-9105	38	17	invasive	invasive	ADJ
ecj-9105	38	18	bacterial	bacterial	ADJ
ecj-9105	38	19	disease	disease	NOUN
ecj-9105	38	20	.	.	PUNCT
ecj-9105	39	1	this	this	DET
ecj-9105	39	2	evaluation	evaluation	NOUN
ecj-9105	39	3	included	include	VERB
ecj-9105	39	4	urine	urine	NOUN
ecj-9105	39	5	exam	exam	NOUN
ecj-9105	39	6	,	,	PUNCT
ecj-9105	39	7	blood	blood	NOUN
ecj-9105	39	8	,	,	PUNCT
ecj-9105	39	9	stool	stool	NOUN
ecj-9105	39	10	and	and	CCONJ
ecj-9105	39	11	cerebro	cerebro	NOUN
ecj-9105	39	12	-	-	PUNCT
ecj-9105	39	13	spinal	spinal	ADJ
ecj-9105	39	14	fluid	fluid	NOUN
ecj-9105	39	15	(	(	PUNCT
ecj-9105	39	16	csf	csf	NOUN
ecj-9105	39	17	)	)	PUNCT
ecj-9105	39	18	cultures	culture	NOUN
ecj-9105	39	19	,	,	PUNCT
ecj-9105	39	20	followed	follow	VERB
ecj-9105	39	21	by	by	ADP
ecj-9105	39	22	empiric	empiric	ADJ
ecj-9105	39	23	antibiotic	antibiotic	ADJ
ecj-9105	39	24	therapy	therapy	NOUN
ecj-9105	39	25	.	.	PUNCT
ecj-9105	40	1	no	no	DET
ecj-9105	40	2	signs	sign	NOUN
ecj-9105	40	3	of	of	ADP
ecj-9105	40	4	urinary	urinary	ADJ
ecj-9105	40	5	infection	infection	NOUN
ecj-9105	40	6	were	be	AUX
ecj-9105	40	7	found	find	VERB
ecj-9105	40	8	;	;	PUNCT
ecj-9105	40	9	csf	csf	PROPN
ecj-9105	40	10	was	be	AUX
ecj-9105	40	11	clear	clear	ADJ
ecj-9105	40	12	,	,	PUNCT
ecj-9105	40	13	with	with	SCONJ
ecj-9105	40	14	normal	normal	ADJ
ecj-9105	40	15	leucocytes	leucocyte	NOUN
ecj-9105	40	16	count	count	VERB
ecj-9105	40	17	and	and	CCONJ
ecj-9105	40	18	glucose	glucose	NOUN
ecj-9105	40	19	level	level	NOUN
ecj-9105	40	20	,	,	PUNCT
ecj-9105	40	21	and	and	CCONJ
ecj-9105	40	22	slightly	slightly	ADV
ecj-9105	40	23	decrease	decrease	NOUN
ecj-9105	40	24	of	of	ADP
ecj-9105	40	25	protein	protein	NOUN
ecj-9105	40	26	(	(	PUNCT
ecj-9105	40	27	14	14	NUM
ecj-9105	40	28	/	/	SYM
ecj-9105	40	29	mg	mg	PROPN
ecj-9105	40	30	/	/	SYM
ecj-9105	40	31	dl	dl	NOUN
ecj-9105	40	32	)	)	PUNCT
ecj-9105	40	33	.	.	PUNCT
ecj-9105	41	1	sars	sars	PROPN
ecj-9105	41	2	-	-	PUNCT
ecj-9105	41	3	cov-2	cov-2	PART
ecj-9105	41	4	realtime	realtime	ADJ
ecj-9105	41	5	rt	rt	ADJ
ecj-9105	41	6	-	-	PUNCT
ecj-9105	41	7	pcr	pcr	NOUN
ecj-9105	41	8	and	and	CCONJ
ecj-9105	41	9	culture	culture	NOUN
ecj-9105	41	10	on	on	ADP
ecj-9105	41	11	csf	csf	ADJ
ecj-9105	41	12	were	be	AUX
ecj-9105	41	13	negative	negative	ADJ
ecj-9105	41	14	.	.	PUNCT
ecj-9105	42	1	coproculture	coproculture	NOUN
ecj-9105	42	2	was	be	AUX
ecj-9105	42	3	negative	negative	ADJ
ecj-9105	42	4	.	.	PUNCT
ecj-9105	43	1	immunological	immunological	ADJ
ecj-9105	43	2	investigation	investigation	NOUN
ecj-9105	43	3	was	be	AUX
ecj-9105	43	4	also	also	ADV
ecj-9105	43	5	performed	perform	VERB
ecj-9105	43	6	.	.	PUNCT
ecj-9105	44	1	tbnk	tbnk	PROPN
ecj-9105	44	2	lymphocyte	lymphocyte	NOUN
ecj-9105	44	3	subset	subset	VERB
ecj-9105	44	4	analysis	analysis	NOUN
ecj-9105	44	5	revealed	reveal	VERB
ecj-9105	44	6	decreased	decrease	VERB
ecj-9105	44	7	percentage	percentage	NOUN
ecj-9105	44	8	of	of	ADP
ecj-9105	44	9	cd4	cd4	PROPN
ecj-9105	44	10	+	+	PROPN
ecj-9105	44	11	(	(	PUNCT
ecj-9105	44	12	23	23	NUM
ecj-9105	44	13	%	%	NOUN
ecj-9105	44	14	,	,	PUNCT
ecj-9105	44	15	normal	normal	ADJ
ecj-9105	44	16	value	value	NOUN
ecj-9105	44	17	44±11	44±11	NUM
ecj-9105	44	18	)	)	PUNCT
ecj-9105	44	19	and	and	CCONJ
ecj-9105	44	20	cd8	cd8	PROPN
ecj-9105	44	21	+	+	PROPN
ecj-9105	44	22	(	(	PUNCT
ecj-9105	44	23	7	7	NUM
ecj-9105	44	24	%	%	NOUN
ecj-9105	44	25	,	,	PUNCT
ecj-9105	44	26	normal	normal	ADJ
ecj-9105	44	27	value	value	NOUN
ecj-9105	44	28	21±9	21±9	NUM
ecj-9105	44	29	)	)	PUNCT
ecj-9105	44	30	cells	cell	NOUN
ecj-9105	44	31	and	and	CCONJ
ecj-9105	44	32	slightly	slightly	ADV
ecj-9105	44	33	low	low	ADJ
ecj-9105	44	34	nk	nk	PROPN
ecj-9105	44	35	cells	cell	NOUN
ecj-9105	44	36	(	(	PUNCT
ecj-9105	44	37	6	6	NUM
ecj-9105	44	38	%	%	NOUN
ecj-9105	44	39	,	,	PUNCT
ecj-9105	44	40	normal	normal	ADJ
ecj-9105	44	41	value	value	NOUN
ecj-9105	44	42	10±3	10±3	NUM
ecj-9105	44	43	)	)	PUNCT
ecj-9105	44	44	.	.	PUNCT
ecj-9105	45	1	cytokine	cytokine	ADJ
ecj-9105	45	2	detection	detection	NOUN
ecj-9105	45	3	assay	assay	NOUN
ecj-9105	45	4	revealed	reveal	VERB
ecj-9105	45	5	increased	increase	VERB
ecj-9105	45	6	levels	level	NOUN
ecj-9105	45	7	of	of	ADP
ecj-9105	45	8	interleukin6	interleukin6	PROPN
ecj-9105	45	9	(	(	PUNCT
ecj-9105	45	10	il-6	il-6	NUM
ecj-9105	45	11	)	)	PUNCT
ecj-9105	45	12	,	,	PUNCT
ecj-9105	45	13	(	(	PUNCT
ecj-9105	45	14	25,9	25,9	NUM
ecj-9105	45	15	pg	pg	NOUN
ecj-9105	45	16	/	/	SYM
ecj-9105	45	17	ml	ml	NOUN
ecj-9105	45	18	,	,	PUNCT
ecj-9105	45	19	normal	normal	ADJ
ecj-9105	45	20	value	value	NOUN
ecj-9105	45	21	0	0	NUM
ecj-9105	45	22	-	-	SYM
ecj-9105	45	23	5	5	NUM
ecj-9105	45	24	pg	pg	NOUN
ecj-9105	45	25	/	/	SYM
ecj-9105	45	26	ml	ml	VERB
ecj-9105	45	27	)	)	PUNCT
ecj-9105	45	28	.	.	PUNCT
ecj-9105	46	1	empiric	empiric	ADJ
ecj-9105	46	2	treatment	treatment	NOUN
ecj-9105	46	3	with	with	ADP
ecj-9105	46	4	parental	parental	ADJ
ecj-9105	46	5	cephalosporin	cephalosporin	NOUN
ecj-9105	46	6	(	(	PUNCT
ecj-9105	46	7	ceftazidime	ceftazidime	NOUN
ecj-9105	46	8	)	)	PUNCT
ecj-9105	46	9	was	be	AUX
ecj-9105	46	10	started	start	VERB
ecj-9105	46	11	.	.	PUNCT
ecj-9105	47	1	considering	consider	VERB
ecj-9105	47	2	the	the	DET
ecj-9105	47	3	poor	poor	ADJ
ecj-9105	47	4	general	general	ADJ
ecj-9105	47	5	conditions	condition	NOUN
ecj-9105	47	6	,	,	PUNCT
ecj-9105	47	7	he	he	PRON
ecj-9105	47	8	was	be	AUX
ecj-9105	47	9	transferred	transfer	VERB
ecj-9105	47	10	to	to	ADP
ecj-9105	47	11	our	our	PRON
ecj-9105	47	12	sub	sub	ADJ
ecj-9105	47	13	-	-	ADJ
ecj-9105	47	14	intensive	intensive	ADJ
ecj-9105	47	15	pediatric	pediatric	ADJ
ecj-9105	47	16	unit	unit	NOUN
ecj-9105	47	17	,	,	PUNCT
ecj-9105	47	18	and	and	CCONJ
ecj-9105	47	19	was	be	AUX
ecj-9105	47	20	treated	treat	VERB
ecj-9105	47	21	according	accord	VERB
ecj-9105	47	22	to	to	ADP
ecj-9105	47	23	pediatric	pediatric	ADJ
ecj-9105	47	24	sepsis	sepsis	NOUN
ecj-9105	47	25	guidelines.7	guidelines.7	NOUN
ecj-9105	47	26	here	here	ADV
ecj-9105	47	27	,	,	PUNCT
ecj-9105	47	28	despite	despite	SCONJ
ecj-9105	47	29	the	the	DET
ecj-9105	47	30	initial	initial	ADJ
ecj-9105	47	31	clinical	clinical	ADJ
ecj-9105	47	32	presentation	presentation	NOUN
ecj-9105	47	33	,	,	PUNCT
ecj-9105	47	34	patient	patient	ADJ
ecj-9105	47	35	conditions	condition	NOUN
ecj-9105	47	36	were	be	AUX
ecj-9105	47	37	stable	stable	ADJ
ecj-9105	47	38	.	.	PUNCT
ecj-9105	48	1	patient	patient	PROPN
ecj-9105	48	2	showed	show	VERB
ecj-9105	48	3	persistent	persistent	ADJ
ecj-9105	48	4	fever	fever	NOUN
ecj-9105	48	5	,	,	PUNCT
ecj-9105	48	6	abdominal	abdominal	ADJ
ecj-9105	48	7	pain	pain	NOUN
ecj-9105	48	8	and	and	CCONJ
ecj-9105	48	9	a	a	DET
ecj-9105	48	10	certain	certain	ADJ
ecj-9105	48	11	degree	degree	NOUN
ecj-9105	48	12	of	of	ADP
ecj-9105	48	13	irritability	irritability	NOUN
ecj-9105	48	14	.	.	PUNCT
ecj-9105	49	1	head	head	NOUN
ecj-9105	49	2	ct	ct	PROPN
ecj-9105	49	3	scan	scan	PROPN
ecj-9105	49	4	was	be	AUX
ecj-9105	49	5	normal	normal	ADJ
ecj-9105	49	6	,	,	PUNCT
ecj-9105	49	7	as	as	ADV
ecj-9105	49	8	well	well	ADV
ecj-9105	49	9	as	as	ADP
ecj-9105	49	10	ultrasound	ultrasound	ADJ
ecj-9105	49	11	scan	scan	NOUN
ecj-9105	49	12	of	of	ADP
ecj-9105	49	13	the	the	DET
ecj-9105	49	14	abdomen	abdoman	NOUN
ecj-9105	49	15	.	.	PUNCT
ecj-9105	50	1	there	there	PRON
ecj-9105	50	2	were	be	VERB
ecj-9105	50	3	no	no	DET
ecj-9105	50	4	signs	sign	NOUN
ecj-9105	50	5	of	of	ADP
ecj-9105	50	6	pulmonary	pulmonary	ADJ
ecj-9105	50	7	dysfunction	dysfunction	NOUN
ecj-9105	50	8	,	,	PUNCT
ecj-9105	50	9	beside	beside	ADP
ecj-9105	50	10	a	a	DET
ecj-9105	50	11	mild	mild	ADJ
ecj-9105	50	12	degree	degree	NOUN
ecj-9105	50	13	of	of	ADP
ecj-9105	50	14	tachypnoea	tachypnoea	NOUN
ecj-9105	50	15	that	that	PRON
ecj-9105	50	16	resolved	resolve	VERB
ecj-9105	50	17	when	when	SCONJ
ecj-9105	50	18	fever	fever	NOUN
ecj-9105	50	19	broke	break	VERB
ecj-9105	50	20	down	down	ADP
ecj-9105	50	21	;	;	PUNCT
ecj-9105	50	22	blood	blood	NOUN
ecj-9105	50	23	gas	gas	NOUN
ecj-9105	50	24	analysis	analysis	NOUN
ecj-9105	50	25	was	be	AUX
ecj-9105	50	26	normal	normal	ADJ
ecj-9105	50	27	and	and	CCONJ
ecj-9105	50	28	the	the	DET
ecj-9105	50	29	patient	patient	NOUN
ecj-9105	50	30	had	have	VERB
ecj-9105	50	31	no	no	DET
ecj-9105	50	32	needs	need	NOUN
ecj-9105	50	33	of	of	ADP
ecj-9105	50	34	oxygen	oxygen	NOUN
ecj-9105	50	35	therapy	therapy	NOUN
ecj-9105	50	36	or	or	CCONJ
ecj-9105	50	37	ventilatory	ventilatory	ADJ
ecj-9105	50	38	assistance	assistance	NOUN
ecj-9105	50	39	.	.	PUNCT
ecj-9105	51	1	laboratory	laboratory	NOUN
ecj-9105	51	2	tests	test	NOUN
ecj-9105	51	3	were	be	AUX
ecj-9105	51	4	then	then	ADV
ecj-9105	51	5	repeated	repeat	VERB
ecj-9105	51	6	after	after	ADP
ecj-9105	51	7	24	24	NUM
ecj-9105	51	8	hours	hour	NOUN
ecj-9105	51	9	(	(	PUNCT
ecj-9105	51	10	table	table	NOUN
ecj-9105	51	11	1	1	NUM
ecj-9105	51	12	)	)	PUNCT
ecj-9105	51	13	.	.	PUNCT
ecj-9105	52	1	blood	blood	NOUN
ecj-9105	52	2	culture	culture	NOUN
ecj-9105	52	3	resulted	result	VERB
ecj-9105	52	4	positive	positive	ADJ
ecj-9105	52	5	for	for	ADP
ecj-9105	52	6	pseudomonas	pseudomona	NOUN
ecj-9105	52	7	aeruginosa	aeruginosa	NOUN
ecj-9105	52	8	susceptible	susceptible	ADJ
ecj-9105	52	9	to	to	ADP
ecj-9105	52	10	cephalosporin	cephalosporin	VERB
ecj-9105	52	11	.	.	PUNCT
ecj-9105	53	1	no	no	DET
ecj-9105	53	2	antiviral	antiviral	ADJ
ecj-9105	53	3	medication	medication	NOUN
ecj-9105	53	4	was	be	AUX
ecj-9105	53	5	used	use	VERB
ecj-9105	53	6	.	.	PUNCT
ecj-9105	54	1	the	the	DET
ecj-9105	54	2	patient	patient	NOUN
ecj-9105	54	3	was	be	AUX
ecj-9105	54	4	transferred	transfer	VERB
ecj-9105	54	5	to	to	ADP
ecj-9105	54	6	the	the	DET
ecj-9105	54	7	pediatric	pediatric	ADJ
ecj-9105	54	8	infectious	infectious	ADJ
ecj-9105	54	9	unit	unit	NOUN
ecj-9105	54	10	to	to	PART
ecj-9105	54	11	continue	continue	VERB
ecj-9105	54	12	antibiotic	antibiotic	ADJ
ecj-9105	54	13	and	and	CCONJ
ecj-9105	54	14	supportive	supportive	ADJ
ecj-9105	54	15	therapy	therapy	NOUN
ecj-9105	54	16	without	without	ADP
ecj-9105	54	17	need	need	NOUN
ecj-9105	54	18	to	to	PART
ecj-9105	54	19	new	new	ADJ
ecj-9105	54	20	admission	admission	NOUN
ecj-9105	54	21	in	in	ADP
ecj-9105	54	22	intensive	intensive	ADJ
ecj-9105	54	23	care	care	NOUN
ecj-9105	54	24	ward	ward	NOUN
ecj-9105	54	25	.	.	PUNCT
ecj-9105	55	1	discussion	discussion	NOUN
ecj-9105	55	2	pediatric	pediatric	ADJ
ecj-9105	55	3	patients	patient	NOUN
ecj-9105	55	4	with	with	ADP
ecj-9105	55	5	covid-19	covid-19	PROPN
ecj-9105	55	6	have	have	VERB
ecj-9105	55	7	their	their	PRON
ecj-9105	55	8	own	own	ADJ
ecj-9105	55	9	clinical	clinical	ADJ
ecj-9105	55	10	features	feature	NOUN
ecj-9105	55	11	and	and	CCONJ
ecj-9105	55	12	different	different	ADJ
ecj-9105	55	13	therapeutic	therapeutic	ADJ
ecj-9105	55	14	response	response	NOUN
ecj-9105	55	15	compared	compare	VERB
ecj-9105	55	16	with	with	ADP
ecj-9105	55	17	adult	adult	NOUN
ecj-9105	55	18	infected	infect	VERB
ecj-9105	55	19	population.8	population.8	ADJ
ecj-9105	55	20	nausea	nausea	NOUN
ecj-9105	55	21	and	and	CCONJ
ecj-9105	55	22	vomiting	vomiting	NOUN
ecj-9105	55	23	have	have	AUX
ecj-9105	55	24	been	be	AUX
ecj-9105	55	25	frequently	frequently	ADV
ecj-9105	55	26	observed	observe	VERB
ecj-9105	55	27	in	in	ADP
ecj-9105	55	28	pediatric	pediatric	ADJ
ecj-9105	55	29	cohort	cohort	NOUN
ecj-9105	55	30	,	,	PUNCT
ecj-9105	55	31	while	while	SCONJ
ecj-9105	55	32	fever	fever	NOUN
ecj-9105	55	33	,	,	PUNCT
ecj-9105	55	34	present	present	ADJ
ecj-9105	55	35	in	in	ADP
ecj-9105	55	36	almost	almost	ADV
ecj-9105	55	37	all	all	PRON
ecj-9105	55	38	infected	infected	ADJ
ecj-9105	55	39	adults	adult	NOUN
ecj-9105	55	40	,	,	PUNCT
ecj-9105	55	41	may	may	AUX
ecj-9105	55	42	be	be	AUX
ecj-9105	55	43	absent	absent	ADJ
ecj-9105	55	44	in	in	ADP
ecj-9105	55	45	a	a	DET
ecj-9105	55	46	percentage	percentage	NOUN
ecj-9105	55	47	of	of	ADP
ecj-9105	55	48	children	child	NOUN
ecj-9105	55	49	,	,	PUNCT
ecj-9105	55	50	even	even	ADV
ecj-9105	55	51	in	in	ADP
ecj-9105	55	52	presence	presence	NOUN
ecj-9105	55	53	of	of	ADP
ecj-9105	55	54	a	a	DET
ecj-9105	55	55	severe	severe	ADJ
ecj-9105	55	56	clinical	clinical	NOUN
ecj-9105	56	1	picture.3,9	picture.3,9	ADJ
ecj-9105	56	2	however	however	ADV
ecj-9105	56	3	,	,	PUNCT
ecj-9105	56	4	respiratory	respiratory	ADJ
ecj-9105	56	5	involvement	involvement	NOUN
ecj-9105	56	6	is	be	AUX
ecj-9105	56	7	reported	report	VERB
ecj-9105	56	8	in	in	ADP
ecj-9105	56	9	almost	almost	ADV
ecj-9105	56	10	all	all	PRON
ecj-9105	56	11	severe	severe	ADJ
ecj-9105	56	12	cases	case	NOUN
ecj-9105	56	13	of	of	ADP
ecj-9105	56	14	pediatric	pediatric	ADJ
ecj-9105	56	15	covid-19	covid-19	PROPN
ecj-9105	56	16	infection.9,10	infection.9,10	PROPN
ecj-9105	56	17	despite	despite	SCONJ
ecj-9105	56	18	the	the	DET
ecj-9105	56	19	absence	absence	NOUN
ecj-9105	56	20	of	of	ADP
ecj-9105	56	21	respiratory	respiratory	ADJ
ecj-9105	56	22	involvement	involvement	NOUN
ecj-9105	56	23	,	,	PUNCT
ecj-9105	56	24	our	our	PRON
ecj-9105	56	25	patient	patient	NOUN
ecj-9105	56	26	was	be	AUX
ecj-9105	56	27	considered	consider	VERB
ecj-9105	56	28	as	as	ADP
ecj-9105	56	29	a	a	DET
ecj-9105	56	30	suspected	suspect	VERB
ecj-9105	56	31	covid-19	covid-19	PROPN
ecj-9105	56	32	case	case	NOUN
ecj-9105	56	33	because	because	SCONJ
ecj-9105	56	34	of	of	ADP
ecj-9105	56	35	presence	presence	NOUN
ecj-9105	56	36	of	of	ADP
ecj-9105	56	37	fever	fever	NOUN
ecj-9105	56	38	.	.	PUNCT
ecj-9105	57	1	considering	consider	VERB
ecj-9105	57	2	the	the	DET
ecj-9105	57	3	mild	mild	ADJ
ecj-9105	57	4	onset	onset	NOUN
ecj-9105	57	5	of	of	ADP
ecj-9105	57	6	covid19	covid19	NOUN
ecj-9105	57	7	disease	disease	NOUN
ecj-9105	57	8	in	in	ADP
ecj-9105	57	9	the	the	DET
ecj-9105	57	10	majority	majority	NOUN
ecj-9105	57	11	of	of	ADP
ecj-9105	57	12	pediatric	pediatric	ADJ
ecj-9105	57	13	patients	patient	NOUN
ecj-9105	57	14	,	,	PUNCT
ecj-9105	57	15	the	the	DET
ecj-9105	57	16	severe	severe	ADJ
ecj-9105	57	17	clinical	clinical	ADJ
ecj-9105	57	18	picture	picture	NOUN
ecj-9105	57	19	of	of	ADP
ecj-9105	57	20	our	our	PRON
ecj-9105	57	21	infant	infant	NOUN
ecj-9105	57	22	led	lead	VERB
ecj-9105	57	23	to	to	PART
ecj-9105	57	24	search	search	VERB
ecj-9105	57	25	for	for	ADP
ecj-9105	57	26	etiologies	etiology	NOUN
ecj-9105	57	27	other	other	ADJ
ecj-9105	57	28	than	than	ADP
ecj-9105	57	29	sarscov-2	sarscov-2	NUM
ecj-9105	57	30	and	and	CCONJ
ecj-9105	57	31	to	to	PART
ecj-9105	57	32	perform	perform	VERB
ecj-9105	57	33	the	the	DET
ecj-9105	57	34	workup	workup	NOUN
ecj-9105	57	35	of	of	ADP
ecj-9105	57	36	potential	potential	ADJ
ecj-9105	57	37	invasive	invasive	ADJ
ecj-9105	57	38	bacterial	bacterial	ADJ
ecj-9105	57	39	disease	disease	NOUN
ecj-9105	57	40	.	.	PUNCT
ecj-9105	58	1	moreover	moreover	ADV
ecj-9105	58	2	,	,	PUNCT
ecj-9105	58	3	in	in	ADP
ecj-9105	58	4	covid-19	covid-19	PROPN
ecj-9105	58	5	patients	patient	NOUN
ecj-9105	58	6	,	,	PUNCT
ecj-9105	58	7	c	c	NOUN
ecj-9105	58	8	-	-	PUNCT
ecj-9105	58	9	reactive	reactive	ADJ
ecj-9105	58	10	protein	protein	NOUN
ecj-9105	58	11	and	and	CCONJ
ecj-9105	58	12	procalcitonin	procalcitonin	ADJ
ecj-9105	58	13	levels	level	NOUN
ecj-9105	58	14	are	be	AUX
ecj-9105	58	15	often	often	ADV
ecj-9105	58	16	normal	normal	ADJ
ecj-9105	58	17	and	and	CCONJ
ecj-9105	58	18	a	a	DET
ecj-9105	58	19	level	level	NOUN
ecj-9105	58	20	of	of	ADP
ecj-9105	58	21	procalcitonin	procalcitonin	ADJ
ecj-9105	58	22	>	>	PROPN
ecj-9105	58	23	0.5	0.5	NUM
ecj-9105	58	24	ng	ng	NOUN
ecj-9105	58	25	/	/	SYM
ecj-9105	58	26	ml	ml	PUNCT
ecj-9105	58	27	usually	usually	ADV
ecj-9105	58	28	suggests	suggest	VERB
ecj-9105	58	29	a	a	DET
ecj-9105	58	30	bacterial	bacterial	ADJ
ecj-9105	58	31	co	co	NOUN
ecj-9105	58	32	-	-	NOUN
ecj-9105	58	33	infection.11	infection.11	ADJ
ecj-9105	58	34	in	in	ADP
ecj-9105	58	35	our	our	PRON
ecj-9105	58	36	case	case	NOUN
ecj-9105	58	37	,	,	PUNCT
ecj-9105	58	38	clinical	clinical	ADJ
ecj-9105	58	39	improvement	improvement	NOUN
ecj-9105	58	40	with	with	ADP
ecj-9105	58	41	empiric	empiric	ADJ
ecj-9105	58	42	antibiotic	antibiotic	ADJ
ecj-9105	58	43	therapy	therapy	NOUN
ecj-9105	58	44	and	and	CCONJ
ecj-9105	58	45	laboratory	laboratory	NOUN
ecj-9105	58	46	results	result	NOUN
ecj-9105	58	47	at	at	ADP
ecj-9105	58	48	baseline	baseline	NOUN
ecj-9105	58	49	strongly	strongly	ADV
ecj-9105	58	50	suggested	suggest	VERB
ecj-9105	58	51	a	a	DET
ecj-9105	58	52	bacterial	bacterial	ADJ
ecj-9105	58	53	etiology	etiology	NOUN
ecj-9105	58	54	,	,	PUNCT
ecj-9105	58	55	subsequently	subsequently	ADV
ecj-9105	58	56	confirmed	confirm	VERB
ecj-9105	58	57	by	by	ADP
ecj-9105	58	58	blood	blood	NOUN
ecj-9105	58	59	culture	culture	NOUN
ecj-9105	58	60	.	.	PUNCT
ecj-9105	59	1	it	it	PRON
ecj-9105	59	2	has	have	AUX
ecj-9105	59	3	been	be	AUX
ecj-9105	59	4	reported	report	VERB
ecj-9105	59	5	that	that	SCONJ
ecj-9105	59	6	the	the	DET
ecj-9105	59	7	essence	essence	NOUN
ecj-9105	59	8	of	of	ADP
ecj-9105	59	9	severe	severe	ADJ
ecj-9105	59	10	covid-19	covid-19	PROPN
ecj-9105	59	11	is	be	AUX
ecj-9105	59	12	a	a	DET
ecj-9105	59	13	sepsis	sepsis	NOUN
ecj-9105	59	14	induced	induce	VERB
ecj-9105	59	15	by	by	ADP
ecj-9105	59	16	viral	viral	ADJ
ecj-9105	59	17	infection.12	infection.12	NOUN
ecj-9105	59	18	unfavourable	unfavourable	ADJ
ecj-9105	59	19	progression	progression	NOUN
ecj-9105	59	20	,	,	PUNCT
ecj-9105	59	21	combined	combine	VERB
ecj-9105	59	22	with	with	ADP
ecj-9105	59	23	a	a	DET
ecj-9105	59	24	high	high	ADJ
ecj-9105	59	25	incidence	incidence	NOUN
ecj-9105	59	26	of	of	ADP
ecj-9105	59	27	sepsis	sepsis	NOUN
ecj-9105	59	28	,	,	PUNCT
ecj-9105	59	29	strongly	strongly	ADV
ecj-9105	59	30	suggest	suggest	VERB
ecj-9105	59	31	the	the	DET
ecj-9105	59	32	involvement	involvement	NOUN
ecj-9105	59	33	of	of	ADP
ecj-9105	59	34	significant	significant	ADJ
ecj-9105	59	35	changes	change	NOUN
ecj-9105	59	36	in	in	ADP
ecj-9105	59	37	the	the	DET
ecj-9105	59	38	host	host	NOUN
ecj-9105	59	39	’s	’s	PART
ecj-9105	59	40	immune	immune	ADJ
ecj-9105	59	41	response	response	NOUN
ecj-9105	59	42	during	during	ADP
ecj-9105	59	43	sars	sar	NOUN
ecj-9105	59	44	-	-	PUNCT
ecj-9105	59	45	cov-2	cov-2	PART
ecj-9105	59	46	infection	infection	NOUN
ecj-9105	59	47	.	.	PUNCT
ecj-9105	60	1	it	it	PRON
ecj-9105	60	2	is	be	AUX
ecj-9105	60	3	reasonable	reasonable	ADJ
ecj-9105	60	4	to	to	PART
ecj-9105	60	5	assess	assess	VERB
ecj-9105	60	6	that	that	SCONJ
ecj-9105	60	7	in	in	ADP
ecj-9105	60	8	our	our	PRON
ecj-9105	60	9	case	case	NOUN
ecj-9105	60	10	the	the	DET
ecj-9105	60	11	compromised	compromise	VERB
ecj-9105	60	12	clinical	clinical	ADJ
ecj-9105	60	13	condition	condition	NOUN
ecj-9105	60	14	and	and	CCONJ
ecj-9105	60	15	the	the	DET
ecj-9105	60	16	laboratory	laboratory	NOUN
ecj-9105	60	17	exams	exam	NOUN
ecj-9105	60	18	were	be	AUX
ecj-9105	60	19	not	not	PART
ecj-9105	60	20	related	relate	VERB
ecj-9105	60	21	to	to	ADP
ecj-9105	60	22	covid-19	covid-19	PROPN
ecj-9105	60	23	infection	infection	NOUN
ecj-9105	60	24	itself	itself	PRON
ecj-9105	60	25	but	but	CCONJ
ecj-9105	60	26	to	to	ADP
ecj-9105	60	27	a	a	DET
ecj-9105	60	28	bacterial	bacterial	ADJ
ecj-9105	60	29	coinfection	coinfection	NOUN
ecj-9105	60	30	.	.	PUNCT
ecj-9105	61	1	however	however	ADV
ecj-9105	61	2	,	,	PUNCT
ecj-9105	61	3	while	while	SCONJ
ecj-9105	61	4	in	in	ADP
ecj-9105	61	5	adult	adult	NOUN
ecj-9105	61	6	cases	case	NOUN
ecj-9105	61	7	with	with	ADP
ecj-9105	61	8	an	an	DET
ecj-9105	61	9	unfavourable	unfavourable	ADJ
ecj-9105	61	10	course	course	NOUN
ecj-9105	61	11	sars	sar	NOUN
ecj-9105	61	12	-	-	PUNCT
ecj-9105	61	13	cov-2	cov-2	PART
ecj-9105	61	14	infection	infection	NOUN
ecj-9105	61	15	itself	itself	PRON
ecj-9105	61	16	presented	present	VERB
ecj-9105	61	17	with	with	ADP
ecj-9105	61	18	a	a	DET
ecj-9105	61	19	severe	severe	ADJ
ecj-9105	61	20	respiratory	respiratory	ADJ
ecj-9105	61	21	involvement	involvement	NOUN
ecj-9105	61	22	,	,	PUNCT
ecj-9105	61	23	our	our	PRON
ecj-9105	61	24	patient	patient	NOUN
ecj-9105	61	25	had	have	VERB
ecj-9105	61	26	a	a	DET
ecj-9105	61	27	clinical	clinical	ADJ
ecj-9105	61	28	silent	silent	ADJ
ecj-9105	61	29	covid-19	covid-19	PROPN
ecj-9105	61	30	infection	infection	NOUN
ecj-9105	61	31	.	.	PUNCT
ecj-9105	62	1	covid-19	covid-19	PROPN
ecj-9105	62	2	can	can	AUX
ecj-9105	62	3	induce	induce	VERB
ecj-9105	62	4	an	an	DET
ecj-9105	62	5	aberrant	aberrant	ADJ
ecj-9105	62	6	non	non	ADJ
ecj-9105	62	7	-	-	ADJ
ecj-9105	62	8	effective	effective	ADJ
ecj-9105	62	9	host	host	NOUN
ecj-9105	62	10	immune	immune	ADJ
ecj-9105	62	11	response	response	NOUN
ecj-9105	62	12	associated	associate	VERB
ecj-9105	62	13	with	with	ADP
ecj-9105	62	14	severe	severe	ADJ
ecj-9105	62	15	lung	lung	NOUN
ecj-9105	62	16	involvement.9	involvement.9	PROPN
ecj-9105	62	17	t	t	NOUN
ecj-9105	62	18	cells	cell	NOUN
ecj-9105	62	19	play	play	VERB
ecj-9105	62	20	a	a	DET
ecj-9105	62	21	critical	critical	ADJ
ecj-9105	62	22	role	role	NOUN
ecj-9105	62	23	in	in	ADP
ecj-9105	62	24	antiviral	antiviral	ADJ
ecj-9105	62	25	immunity	immunity	NOUN
ecj-9105	62	26	.	.	PUNCT
ecj-9105	63	1	it	it	PRON
ecj-9105	63	2	has	have	AUX
ecj-9105	63	3	been	be	AUX
ecj-9105	63	4	reported	report	VERB
ecj-9105	63	5	that	that	SCONJ
ecj-9105	63	6	t	t	PROPN
ecj-9105	63	7	cell	cell	NOUN
ecj-9105	63	8	counts	count	NOUN
ecj-9105	63	9	are	be	AUX
ecj-9105	63	10	significantly	significantly	ADV
ecj-9105	63	11	reduced	reduce	VERB
ecj-9105	63	12	in	in	ADP
ecj-9105	63	13	covid-19	covid-19	PROPN
ecj-9105	63	14	patients	patient	NOUN
ecj-9105	63	15	,	,	PUNCT
ecj-9105	63	16	and	and	CCONJ
ecj-9105	63	17	the	the	DET
ecj-9105	63	18	surviving	survive	VERB
ecj-9105	63	19	t	t	PROPN
ecj-9105	63	20	cells	cell	NOUN
ecj-9105	63	21	appear	appear	VERB
ecj-9105	63	22	functionally	functionally	ADV
ecj-9105	63	23	exhausted.4	exhausted.4	ADJ
ecj-9105	63	24	low	low	ADJ
ecj-9105	63	25	t	t	NOUN
ecj-9105	63	26	cell	cell	NOUN
ecj-9105	63	27	count	count	NOUN
ecj-9105	63	28	might	might	AUX
ecj-9105	63	29	be	be	AUX
ecj-9105	63	30	predictive	predictive	ADJ
ecj-9105	63	31	of	of	ADP
ecj-9105	63	32	further	further	ADJ
ecj-9105	63	33	clinical	clinical	ADJ
ecj-9105	63	34	deterioration	deterioration	NOUN
ecj-9105	63	35	;	;	PUNCT
ecj-9105	63	36	as	as	ADP
ecj-9105	63	37	a	a	DET
ecj-9105	63	38	consequence	consequence	NOUN
ecj-9105	63	39	,	,	PUNCT
ecj-9105	63	40	early	early	ADJ
ecj-9105	63	41	and	and	CCONJ
ecj-9105	63	42	more	more	ADV
ecj-9105	63	43	aggressive	aggressive	ADJ
ecj-9105	63	44	therapeutic	therapeutic	ADJ
ecj-9105	63	45	interventions	intervention	NOUN
ecj-9105	63	46	may	may	AUX
ecj-9105	63	47	be	be	AUX
ecj-9105	63	48	required	require	VERB
ecj-9105	63	49	in	in	ADP
ecj-9105	63	50	these	these	DET
ecj-9105	63	51	patients	patient	NOUN
ecj-9105	63	52	.	.	PUNCT
ecj-9105	64	1	our	our	PRON
ecj-9105	64	2	patient	patient	NOUN
ecj-9105	64	3	underwent	undergo	VERB
ecj-9105	64	4	a	a	PRON
ecj-9105	64	5	decreased	decrease	VERB
ecj-9105	64	6	in	in	ADP
ecj-9105	64	7	total	total	ADJ
ecj-9105	64	8	t	t	NOUN
ecj-9105	64	9	cells	cell	NOUN
ecj-9105	64	10	,	,	PUNCT
ecj-9105	64	11	cd4	cd4	PROPN
ecj-9105	64	12	+	+	PROPN
ecj-9105	64	13	t	t	PROPN
ecj-9105	64	14	and	and	CCONJ
ecj-9105	64	15	nk	nk	PROPN
ecj-9105	64	16	cells	cell	NOUN
ecj-9105	64	17	,	,	PUNCT
ecj-9105	64	18	and	and	CCONJ
ecj-9105	64	19	mostly	mostly	ADV
ecj-9105	64	20	importantly	importantly	ADV
ecj-9105	64	21	in	in	ADP
ecj-9105	64	22	cd8	cd8	PROPN
ecj-9105	64	23	+	+	PROPN
ecj-9105	64	24	t	t	NOUN
ecj-9105	64	25	cells	cell	NOUN
ecj-9105	64	26	.	.	PUNCT
ecj-9105	65	1	cytokine	cytokine	NOUN
ecj-9105	65	2	storm	storm	NOUN
ecj-9105	65	3	is	be	AUX
ecj-9105	65	4	a	a	DET
ecj-9105	65	5	well	well	ADV
ecj-9105	65	6	-	-	PUNCT
ecj-9105	65	7	known	know	VERB
ecj-9105	65	8	phenomenon	phenomenon	NOUN
ecj-9105	65	9	in	in	ADP
ecj-9105	65	10	respiratory	respiratory	ADJ
ecj-9105	65	11	viral	viral	ADJ
ecj-9105	65	12	infections	infection	NOUN
ecj-9105	65	13	.	.	PUNCT
ecj-9105	66	1	in	in	ADP
ecj-9105	66	2	sars	sars	PROPN
ecj-9105	66	3	-	-	PUNCT
ecj-9105	66	4	cov-2	cov-2	PART
ecj-9105	66	5	adults	adult	NOUN
ecj-9105	66	6	increased	increase	VERB
ecj-9105	66	7	plasma	plasma	NOUN
ecj-9105	66	8	concentrations	concentration	NOUN
ecj-9105	66	9	of	of	ADP
ecj-9105	66	10	pro	pro	ADJ
ecj-9105	66	11	-	-	ADJ
ecj-9105	66	12	inflammatory	inflammatory	ADJ
ecj-9105	66	13	cytokines	cytokine	NOUN
ecj-9105	66	14	has	have	AUX
ecj-9105	66	15	been	be	AUX
ecj-9105	66	16	found.4,13	found.4,13	ADJ
ecj-9105	66	17	in	in	ADP
ecj-9105	66	18	our	our	PRON
ecj-9105	66	19	patient	patient	NOUN
ecj-9105	66	20	,	,	PUNCT
ecj-9105	66	21	we	we	PRON
ecj-9105	66	22	found	find	VERB
ecj-9105	66	23	an	an	DET
ecj-9105	66	24	increased	increase	VERB
ecj-9105	66	25	secretion	secretion	NOUN
ecj-9105	66	26	of	of	ADP
ecj-9105	66	27	il-6	il-6	NOUN
ecj-9105	66	28	.	.	PUNCT
ecj-9105	67	1	this	this	DET
ecj-9105	67	2	case	case	NOUN
ecj-9105	67	3	report	report	NOUN
ecj-9105	67	4	table	table	NOUN
ecj-9105	67	5	1	1	NUM
ecj-9105	67	6	.	.	PUNCT
ecj-9105	68	1	patient	patient	ADJ
ecj-9105	68	2	laboratory	laboratory	NOUN
ecj-9105	68	3	results	result	NOUN
ecj-9105	68	4	per	per	ADP
ecj-9105	68	5	hour	hour	NOUN
ecj-9105	68	6	since	since	SCONJ
ecj-9105	68	7	admission	admission	NOUN
ecj-9105	68	8	.	.	PUNCT
ecj-9105	69	1	test	test	NOUN
ecj-9105	69	2	time	time	NOUN
ecj-9105	69	3	(	(	PUNCT
ecj-9105	69	4	hours	hour	NOUN
ecj-9105	69	5	):	):	PUNCT
ecj-9105	69	6	admission	admission	NOUN
ecj-9105	69	7	12	12	NUM
ecj-9105	69	8	cbc	cbc	NOUN
ecj-9105	69	9	hb	hb	PROPN
ecj-9105	69	10	/	/	SYM
ecj-9105	69	11	hct	hct	NOUN
ecj-9105	69	12	(	(	PUNCT
ecj-9105	69	13	g	g	NOUN
ecj-9105	69	14	/	/	SYM
ecj-9105	69	15	dl)/(%	dl)/(%	NUM
ecj-9105	69	16	)	)	PUNCT
ecj-9105	69	17	9.0/26.10	9.0/26.10	PROPN
ecj-9105	69	18	8.0/23.30	8.0/23.30	PROPN
ecj-9105	69	19	wbc	wbc	PROPN
ecj-9105	69	20	(	(	PUNCT
ecj-9105	69	21	x	x	NOUN
ecj-9105	69	22	103/µl	103/µl	X
ecj-9105	69	23	)	)	PUNCT
ecj-9105	69	24	1.84	1.84	NUM
ecj-9105	69	25	0.91	0.91	NUM
ecj-9105	69	26	neutrophils	neutrophil	NOUN
ecj-9105	69	27	(	(	PUNCT
ecj-9105	69	28	x	x	NOUN
ecj-9105	69	29	103/µl	103/µl	NUM
ecj-9105	69	30	)	)	PUNCT
ecj-9105	69	31	0.48	0.48	NUM
ecj-9105	69	32	0.31	0.31	NUM
ecj-9105	69	33	lymphocyte	lymphocyte	NOUN
ecj-9105	69	34	(	(	PUNCT
ecj-9105	69	35	x	x	NOUN
ecj-9105	69	36	1033/µl	1033/µl	NUM
ecj-9105	69	37	)	)	PUNCT
ecj-9105	69	38	0.81	0.81	NUM
ecj-9105	69	39	0.45	0.45	NUM
ecj-9105	69	40	monocytes	monocyte	NOUN
ecj-9105	69	41	(	(	PUNCT
ecj-9105	69	42	x	x	NOUN
ecj-9105	69	43	103/µl	103/µl	NUM
ecj-9105	69	44	)	)	PUNCT
ecj-9105	69	45	0.62	0.62	NUM
ecj-9105	69	46	0.15	0.15	NUM
ecj-9105	69	47	plt	plt	NOUN
ecj-9105	69	48	(	(	PUNCT
ecj-9105	69	49	x	x	NOUN
ecj-9105	69	50	1033/µl	1033/µl	NUM
ecj-9105	69	51	)	)	PUNCT
ecj-9105	69	52	336	336	NUM
ecj-9105	69	53	266	266	NUM
ecj-9105	69	54	cmp	cmp	NOUN
ecj-9105	69	55	bun	bun	PROPN
ecj-9105	69	56	/	/	SYM
ecj-9105	69	57	cr	cr	PROPN
ecj-9105	69	58	(	(	PUNCT
ecj-9105	69	59	mg	mg	PROPN
ecj-9105	69	60	/	/	SYM
ecj-9105	69	61	dl	dl	PROPN
ecj-9105	69	62	)	)	PUNCT
ecj-9105	69	63	/(g	/(g	PUNCT
ecj-9105	69	64	/	/	SYM
ecj-9105	69	65	dl	dl	PROPN
ecj-9105	69	66	)	)	PUNCT
ecj-9105	69	67	16/0.23	16/0.23	PROPN
ecj-9105	69	68	19/0.21	19/0.21	NUM
ecj-9105	69	69	ast	ast	NOUN
ecj-9105	69	70	/	/	SYM
ecj-9105	69	71	alt	alt	PROPN
ecj-9105	69	72	(	(	PUNCT
ecj-9105	69	73	units	unit	NOUN
ecj-9105	69	74	/	/	SYM
ecj-9105	69	75	l	l	NOUN
ecj-9105	69	76	)	)	PUNCT
ecj-9105	69	77	25/42	25/42	NUM
ecj-9105	69	78	lug-26	lug-26	NOUN
ecj-9105	69	79	inflammatory	inflammatory	ADJ
ecj-9105	69	80	markers	marker	NOUN
ecj-9105	69	81	pct	pct	NOUN
ecj-9105	69	82	(	(	PUNCT
ecj-9105	69	83	ng	ng	PROPN
ecj-9105	69	84	/	/	SYM
ecj-9105	69	85	ml	ml	PROPN
ecj-9105	69	86	)	)	PUNCT
ecj-9105	69	87	61.34	61.34	NUM
ecj-9105	69	88	38.60	38.60	NUM
ecj-9105	69	89	crp	crp	NOUN
ecj-9105	69	90	(	(	PUNCT
ecj-9105	69	91	mg	mg	PROPN
ecj-9105	69	92	/	/	SYM
ecj-9105	69	93	l	l	NOUN
ecj-9105	69	94	)	)	PUNCT
ecj-9105	69	95	412.76	412.76	NUM
ecj-9105	69	96	338.06	338.06	NUM
ecj-9105	69	97	ferritin(ng	ferritin(ng	NOUN
ecj-9105	69	98	/	/	SYM
ecj-9105	69	99	ml	ml	NOUN
ecj-9105	69	100	)	)	PUNCT
ecj-9105	69	101	686.00	686.00	NUM
ecj-9105	69	102	785.50	785.50	NUM
ecj-9105	69	103	albumin	albumin	NOUN
ecj-9105	69	104	(	(	PUNCT
ecj-9105	69	105	g	g	PROPN
ecj-9105	69	106	/	/	SYM
ecj-9105	69	107	dl	dl	NOUN
ecj-9105	69	108	)	)	PUNCT
ecj-9105	69	109	3.0	3.0	NUM
ecj-9105	69	110	2.8	2.8	NUM
ecj-9105	69	111	d	d	NOUN
ecj-9105	69	112	-	-	PUNCT
ecj-9105	69	113	dimero	dimero	NOUN
ecj-9105	69	114	(	(	PUNCT
ecj-9105	69	115	ng	ng	NOUN
ecj-9105	69	116	/	/	SYM
ecj-9105	69	117	ml	ml	PROPN
ecj-9105	69	118	)	)	PUNCT
ecj-9105	69	119	1300.00	1300.00	NUM
ecj-9105	69	120	cbc	cbc	NOUN
ecj-9105	69	121	:	:	PUNCT
ecj-9105	69	122	complete	complete	ADJ
ecj-9105	69	123	blood	blood	NOUN
ecj-9105	69	124	cell	cell	NOUN
ecj-9105	69	125	count	count	NOUN
ecj-9105	69	126	;	;	PUNCT
ecj-9105	69	127	hb	hb	PROPN
ecj-9105	69	128	:	:	PUNCT
ecj-9105	69	129	hemoglobin	hemoglobin	NOUN
ecj-9105	69	130	;	;	PUNCT
ecj-9105	69	131	hct	hct	PROPN
ecj-9105	69	132	:	:	PUNCT
ecj-9105	69	133	hematocrit	hematocrit	PROPN
ecj-9105	69	134	;	;	PUNCT
ecj-9105	69	135	wbc	wbc	PROPN
ecj-9105	69	136	:	:	PUNCT
ecj-9105	69	137	white	white	ADJ
ecj-9105	69	138	blood	blood	NOUN
ecj-9105	69	139	cells	cell	NOUN
ecj-9105	69	140	;	;	PUNCT
ecj-9105	69	141	plt	plt	NOUN
ecj-9105	69	142	:	:	PUNCT
ecj-9105	69	143	platelets	platelet	NOUN
ecj-9105	69	144	;	;	PUNCT
ecj-9105	69	145	cmp	cmp	NOUN
ecj-9105	69	146	:	:	PUNCT
ecj-9105	69	147	comprehensive	comprehensive	ADJ
ecj-9105	69	148	metabolic	metabolic	PROPN
ecj-9105	69	149	panel	panel	NOUN
ecj-9105	69	150	;	;	PUNCT
ecj-9105	69	151	bun	bun	NOUN
ecj-9105	69	152	:	:	PUNCT
ecj-9105	69	153	blood	blood	NOUN
ecj-9105	69	154	urea	urea	NOUN
ecj-9105	69	155	nitrogen	nitrogen	NOUN
ecj-9105	69	156	test	test	NOUN
ecj-9105	69	157	(	(	PUNCT
ecj-9105	69	158	n.v	n.v	NOUN
ecj-9105	69	159	.	.	PROPN
ecj-9105	69	160	10	10	NUM
ecj-9105	69	161	-	-	SYM
ecj-9105	69	162	38	38	NUM
ecj-9105	69	163	mg	mg	PROPN
ecj-9105	69	164	/	/	SYM
ecj-9105	69	165	dl	dl	PROPN
ecj-9105	69	166	)	)	PUNCT
ecj-9105	69	167	;	;	PUNCT
ecj-9105	69	168	cr	cr	X
ecj-9105	69	169	:	:	PUNCT
ecj-9105	69	170	creatinine	creatinine	NOUN
ecj-9105	69	171	(	(	PUNCT
ecj-9105	69	172	n.v	n.v	NOUN
ecj-9105	69	173	.	.	PROPN
ecj-9105	69	174	0.10	0.10	NUM
ecj-9105	69	175	-	-	SYM
ecj-9105	69	176	0.40	0.40	NUM
ecj-9105	69	177	mg	mg	PROPN
ecj-9105	69	178	/	/	SYM
ecj-9105	69	179	dl	dl	PROPN
ecj-9105	69	180	)	)	PUNCT
ecj-9105	69	181	;	;	PUNCT
ecj-9105	69	182	ast	ast	ADJ
ecj-9105	69	183	:	:	PUNCT
ecj-9105	69	184	aspartate	aspartate	NOUN
ecj-9105	69	185	aminotransferase	aminotransferase	PROPN
ecj-9105	69	186	(	(	PUNCT
ecj-9105	69	187	n.v	n.v	PROPN
ecj-9105	69	188	.	.	PROPN
ecj-9105	69	189	5	5	NUM
ecj-9105	69	190	-	-	SYM
ecj-9105	69	191	58	58	NUM
ecj-9105	69	192	u	u	NOUN
ecj-9105	69	193	/	/	SYM
ecj-9105	69	194	l	l	NOUN
ecj-9105	69	195	;	;	PUNCT
ecj-9105	69	196	alt	alt	ADJ
ecj-9105	69	197	:	:	PUNCT
ecj-9105	69	198	alanine	alanine	NOUN
ecj-9105	69	199	aminotransferase	aminotransferase	PROPN
ecj-9105	69	200	(	(	PUNCT
ecj-9105	69	201	n.v	n.v	PROPN
ecj-9105	69	202	.	.	PROPN
ecj-9105	69	203	8	8	NUM
ecj-9105	69	204	-	-	SYM
ecj-9105	69	205	40	40	NUM
ecj-9105	69	206	u	u	NOUN
ecj-9105	69	207	/	/	SYM
ecj-9105	69	208	l	l	NOUN
ecj-9105	69	209	)	)	PUNCT
ecj-9105	69	210	;	;	PUNCT
ecj-9105	69	211	pct	pct	NOUN
ecj-9105	69	212	:	:	PUNCT
ecj-9105	69	213	procalcitonin	procalcitonin	ADJ
ecj-9105	69	214	(	(	PUNCT
ecj-9105	69	215	n.v	n.v	PROPN
ecj-9105	69	216	.	.	PROPN
ecj-9105	69	217	:	:	PUNCT
ecj-9105	69	218	0.0	0.0	NUM
ecj-9105	69	219	–	–	SYM
ecj-9105	69	220	0.5	0.5	NUM
ecj-9105	69	221	ng	ng	PROPN
ecj-9105	69	222	/	/	SYM
ecj-9105	69	223	ml	ml	PROPN
ecj-9105	69	224	)	)	PUNCT
ecj-9105	69	225	;	;	PUNCT
ecj-9105	69	226	crp	crp	NOUN
ecj-9105	69	227	:	:	PUNCT
ecj-9105	69	228	c	c	X
ecj-9105	69	229	-	-	PUNCT
ecj-9105	69	230	reactive	reactive	ADJ
ecj-9105	69	231	protein	protein	NOUN
ecj-9105	69	232	(	(	PUNCT
ecj-9105	69	233	n.v	n.v	PROPN
ecj-9105	69	234	.	.	NOUN
ecj-9105	69	235	0.0	0.0	NUM
ecj-9105	69	236	-	-	PUNCT
ecj-9105	69	237	5.0mg	5.0mg	NUM
ecj-9105	69	238	/	/	SYM
ecj-9105	69	239	l	l	NOUN
ecj-9105	69	240	)	)	PUNCT
ecj-9105	69	241	;	;	PUNCT
ecj-9105	69	242	ferritin	ferritin	X
ecj-9105	69	243	(	(	PUNCT
ecj-9105	69	244	n.v	n.v	PROPN
ecj-9105	69	245	.	.	PROPN
ecj-9105	69	246	10.00320.00	10.00320.00	NUM
ecj-9105	69	247	ng	ng	PROPN
ecj-9105	69	248	/	/	SYM
ecj-9105	69	249	ml	ml	PROPN
ecj-9105	69	250	)	)	PUNCT
ecj-9105	69	251	;	;	PUNCT
ecj-9105	69	252	albumin	albumin	NOUN
ecj-9105	69	253	(	(	PUNCT
ecj-9105	69	254	n.v	n.v	PROPN
ecj-9105	69	255	.	.	PROPN
ecj-9105	69	256	3.4	3.4	NUM
ecj-9105	69	257	-	-	SYM
ecj-9105	69	258	4.8	4.8	NUM
ecj-9105	69	259	g	g	NOUN
ecj-9105	69	260	/	/	SYM
ecj-9105	69	261	dl	dl	PROPN
ecj-9105	69	262	)	)	PUNCT
ecj-9105	69	263	;	;	PUNCT
ecj-9105	69	264	d	d	X
ecj-9105	69	265	-	-	PUNCT
ecj-9105	69	266	dimero	dimero	NOUN
ecj-9105	69	267	(	(	PUNCT
ecj-9105	69	268	n.v	n.v	NOUN
ecj-9105	69	269	.	.	PROPN
ecj-9105	69	270	0.00	0.00	NUM
ecj-9105	69	271	-	-	SYM
ecj-9105	69	272	270.00	270.00	NUM
ecj-9105	69	273	ng	ng	PROPN
ecj-9105	69	274	/	/	SYM
ecj-9105	69	275	ml	ml	NOUN
ecj-9105	69	276	)	)	PUNCT
ecj-9105	70	1	[	[	X
ecj-9105	70	2	page	page	NOUN
ecj-9105	70	3	156	156	NUM
ecj-9105	70	4	]	]	PUNCT
ecj-9105	71	1	[	[	X
ecj-9105	71	2	emergency	emergency	NOUN
ecj-9105	71	3	care	care	NOUN
ecj-9105	71	4	journal	journal	NOUN
ecj-9105	71	5	2020	2020	NUM
ecj-9105	71	6	;	;	PUNCT
ecj-9105	71	7	16:9105	16:9105	NUM
ecj-9105	71	8	]	]	X
ecj-9105	71	9	non	non	ADJ
ecj-9105	71	10	-co	-co	PROPN
ecj-9105	71	11	mmerc	mmerc	PROPN
ecj-9105	71	12	ial	ial	PROPN
ecj-9105	71	13	us	us	PROPN
ecj-9105	71	14	e	e	NOUN
ecj-9105	71	15	o	o	X
ecj-9105	71	16	nly	nly	ADV
ecj-9105	71	17	[	[	X
ecj-9105	71	18	emergency	emergency	NOUN
ecj-9105	71	19	care	care	NOUN
ecj-9105	71	20	journal	journal	NOUN
ecj-9105	71	21	2020	2020	NUM
ecj-9105	71	22	;	;	PUNCT
ecj-9105	71	23	16:9105	16:9105	NUM
ecj-9105	71	24	]	]	PUNCT
ecj-9105	72	1	[	[	X
ecj-9105	72	2	page	page	NOUN
ecj-9105	72	3	157	157	NUM
ecj-9105	72	4	]	]	PUNCT
ecj-9105	72	5	cytokine	cytokine	NOUN
ecj-9105	72	6	plays	play	VERB
ecj-9105	72	7	a	a	DET
ecj-9105	72	8	pathological	pathological	ADJ
ecj-9105	72	9	role	role	NOUN
ecj-9105	72	10	in	in	ADP
ecj-9105	72	11	acute	acute	ADJ
ecj-9105	72	12	and	and	CCONJ
ecj-9105	72	13	chronic	chronic	ADJ
ecj-9105	72	14	inflammation	inflammation	NOUN
ecj-9105	72	15	and	and	CCONJ
ecj-9105	72	16	infection.14	infection.14	NOUN
ecj-9105	72	17	furthermore	furthermore	ADV
ecj-9105	72	18	,	,	PUNCT
ecj-9105	72	19	il-6	il-6	PRON
ecj-9105	72	20	causes	cause	VERB
ecj-9105	72	21	compromised	compromise	VERB
ecj-9105	72	22	tissue	tissue	NOUN
ecj-9105	72	23	repair	repair	NOUN
ecj-9105	72	24	by	by	ADP
ecj-9105	72	25	shifting	shift	VERB
ecj-9105	72	26	acute	acute	ADJ
ecj-9105	72	27	inflammation	inflammation	NOUN
ecj-9105	72	28	into	into	ADP
ecj-9105	72	29	a	a	DET
ecj-9105	72	30	more	more	ADV
ecj-9105	72	31	chronic	chronic	ADJ
ecj-9105	72	32	profibrotic	profibrotic	ADJ
ecj-9105	72	33	state	state	NOUN
ecj-9105	72	34	through	through	ADP
ecj-9105	72	35	induction	induction	NOUN
ecj-9105	72	36	of	of	ADP
ecj-9105	72	37	th1	th1	PROPN
ecj-9105	72	38	cell	cell	NOUN
ecj-9105	72	39	responses	response	NOUN
ecj-9105	72	40	as	as	ADP
ecj-9105	72	41	a	a	DET
ecj-9105	72	42	consequence	consequence	NOUN
ecj-9105	72	43	of	of	ADP
ecj-9105	72	44	recurrent	recurrent	ADJ
ecj-9105	72	45	inflammation.15	inflammation.15	NOUN
ecj-9105	72	46	it	it	PRON
ecj-9105	72	47	is	be	AUX
ecj-9105	72	48	possible	possible	ADJ
ecj-9105	72	49	to	to	PART
ecj-9105	72	50	hypothesize	hypothesize	VERB
ecj-9105	72	51	that	that	SCONJ
ecj-9105	72	52	these	these	DET
ecj-9105	72	53	covid-19	covid-19	PROPN
ecj-9105	72	54	induced	induce	VERB
ecj-9105	72	55	changes	change	NOUN
ecj-9105	72	56	in	in	ADP
ecj-9105	72	57	immune	immune	ADJ
ecj-9105	72	58	response	response	NOUN
ecj-9105	72	59	might	might	AUX
ecj-9105	72	60	have	have	AUX
ecj-9105	72	61	led	lead	VERB
ecj-9105	72	62	to	to	ADP
ecj-9105	72	63	an	an	DET
ecj-9105	72	64	increased	increase	VERB
ecj-9105	72	65	susceptibility	susceptibility	NOUN
ecj-9105	72	66	to	to	PART
ecj-9105	72	67	develop	develop	VERB
ecj-9105	72	68	a	a	DET
ecj-9105	72	69	bacterial	bacterial	ADJ
ecj-9105	72	70	infection	infection	NOUN
ecj-9105	72	71	in	in	ADP
ecj-9105	72	72	our	our	PRON
ecj-9105	72	73	otherwise	otherwise	ADV
ecj-9105	72	74	healthy	healthy	ADJ
ecj-9105	72	75	infant	infant	NOUN
ecj-9105	72	76	.	.	PUNCT
ecj-9105	73	1	as	as	ADP
ecj-9105	73	2	for	for	ADP
ecj-9105	73	3	the	the	DET
ecj-9105	73	4	specific	specific	ADJ
ecj-9105	73	5	etiology	etiology	NOUN
ecj-9105	73	6	,	,	PUNCT
ecj-9105	73	7	sepsis	sepsis	NOUN
ecj-9105	73	8	due	due	ADP
ecj-9105	73	9	to	to	ADP
ecj-9105	73	10	pseudomonas	pseudomona	NOUN
ecj-9105	73	11	aeruginosa	aeruginosa	NOUN
ecj-9105	73	12	commonly	commonly	ADV
ecj-9105	73	13	is	be	AUX
ecj-9105	73	14	usually	usually	ADV
ecj-9105	73	15	hospital	hospital	NOUN
ecj-9105	73	16	-	-	PUNCT
ecj-9105	73	17	acquired	acquire	VERB
ecj-9105	73	18	and	and	CCONJ
ecj-9105	73	19	affects	affect	VERB
ecj-9105	73	20	children	child	NOUN
ecj-9105	73	21	with	with	ADP
ecj-9105	73	22	underlying	underlie	VERB
ecj-9105	73	23	clinical	clinical	ADJ
ecj-9105	73	24	conditions	condition	NOUN
ecj-9105	73	25	.	.	PUNCT
ecj-9105	74	1	on	on	ADP
ecj-9105	74	2	the	the	DET
ecj-9105	74	3	other	other	ADJ
ecj-9105	74	4	hand	hand	NOUN
ecj-9105	74	5	,	,	PUNCT
ecj-9105	74	6	although	although	SCONJ
ecj-9105	74	7	the	the	DET
ecj-9105	74	8	gastrointestinal	gastrointestinal	ADJ
ecj-9105	74	9	tract	tract	NOUN
ecj-9105	74	10	is	be	AUX
ecj-9105	74	11	not	not	PART
ecj-9105	74	12	the	the	DET
ecj-9105	74	13	common	common	ADJ
ecj-9105	74	14	infection	infection	NOUN
ecj-9105	74	15	site	site	NOUN
ecj-9105	74	16	of	of	ADP
ecj-9105	74	17	pseudomonas	pseudomona	NOUN
ecj-9105	74	18	aeruginosa	aeruginosa	NOUN
ecj-9105	74	19	,	,	PUNCT
ecj-9105	74	20	it	it	PRON
ecj-9105	74	21	has	have	AUX
ecj-9105	74	22	been	be	AUX
ecj-9105	74	23	reported	report	VERB
ecj-9105	74	24	that	that	SCONJ
ecj-9105	74	25	it	it	PRON
ecj-9105	74	26	can	can	AUX
ecj-9105	74	27	be	be	AUX
ecj-9105	74	28	a	a	DET
ecj-9105	74	29	causative	causative	ADJ
ecj-9105	74	30	agent	agent	NOUN
ecj-9105	74	31	for	for	ADP
ecj-9105	74	32	diarrhea	diarrhea	NOUN
ecj-9105	74	33	in	in	ADP
ecj-9105	74	34	children	child	NOUN
ecj-9105	74	35	without	without	ADP
ecj-9105	74	36	pre	pre	ADJ
ecj-9105	74	37	-	-	ADJ
ecj-9105	74	38	existing	exist	VERB
ecj-9105	74	39	disease.16	disease.16	NOUN
ecj-9105	74	40	the	the	DET
ecj-9105	74	41	impaired	impaired	ADJ
ecj-9105	74	42	host	host	NOUN
ecj-9105	74	43	immune	immune	ADJ
ecj-9105	74	44	response	response	NOUN
ecj-9105	74	45	covid-19	covid-19	PROPN
ecj-9105	74	46	induced	induce	VERB
ecj-9105	74	47	could	could	AUX
ecj-9105	74	48	have	have	AUX
ecj-9105	74	49	promoted	promote	VERB
ecj-9105	74	50	translocation	translocation	NOUN
ecj-9105	74	51	of	of	ADP
ecj-9105	74	52	pseudomonas	pseudomona	NOUN
ecj-9105	74	53	aeruginosa	aeruginosa	NOUN
ecj-9105	74	54	in	in	ADP
ecj-9105	74	55	bloodstream	bloodstream	NOUN
ecj-9105	74	56	.	.	PUNCT
ecj-9105	75	1	in	in	ADP
ecj-9105	75	2	literature	literature	NOUN
ecj-9105	75	3	,	,	PUNCT
ecj-9105	75	4	few	few	ADJ
ecj-9105	75	5	cases	case	NOUN
ecj-9105	75	6	of	of	ADP
ecj-9105	75	7	infants	infant	NOUN
ecj-9105	75	8	with	with	ADP
ecj-9105	75	9	covid-19	covid-19	PROPN
ecj-9105	75	10	infection	infection	NOUN
ecj-9105	75	11	and	and	CCONJ
ecj-9105	75	12	clinical	clinical	ADJ
ecj-9105	75	13	signs	sign	NOUN
ecj-9105	75	14	of	of	ADP
ecj-9105	75	15	sepsis	sepsis	NOUN
ecj-9105	75	16	have	have	AUX
ecj-9105	75	17	been	be	AUX
ecj-9105	75	18	reported	report	VERB
ecj-9105	75	19	but	but	CCONJ
ecj-9105	75	20	in	in	ADP
ecj-9105	75	21	none	none	NOUN
ecj-9105	75	22	of	of	ADP
ecj-9105	75	23	them	they	PRON
ecj-9105	75	24	a	a	DET
ecj-9105	75	25	confirmed	confirm	VERB
ecj-9105	75	26	bacterial	bacterial	ADJ
ecj-9105	75	27	etiology	etiology	NOUN
ecj-9105	75	28	of	of	ADP
ecj-9105	75	29	sepsis	sepsis	NOUN
ecj-9105	75	30	has	have	AUX
ecj-9105	75	31	been	be	AUX
ecj-9105	75	32	found.17,18	found.17,18	ADJ
ecj-9105	75	33	conclusions	conclusion	NOUN
ecj-9105	75	34	in	in	ADP
ecj-9105	75	35	children	child	NOUN
ecj-9105	75	36	with	with	ADP
ecj-9105	75	37	non	non	ADJ
ecj-9105	75	38	-	-	ADJ
ecj-9105	75	39	specific	specific	ADJ
ecj-9105	75	40	symptoms	symptom	NOUN
ecj-9105	75	41	of	of	ADP
ecj-9105	75	42	covid	covid	ADJ
ecj-9105	75	43	infection	infection	NOUN
ecj-9105	75	44	,	,	PUNCT
ecj-9105	75	45	with	with	ADP
ecj-9105	75	46	a	a	DET
ecj-9105	75	47	familial	familial	ADJ
ecj-9105	75	48	history	history	NOUN
ecj-9105	75	49	of	of	ADP
ecj-9105	75	50	fever	fever	NOUN
ecj-9105	75	51	and/or	and/or	CCONJ
ecj-9105	75	52	respiratory	respiratory	ADJ
ecj-9105	75	53	involvement	involvement	NOUN
ecj-9105	75	54	and/or	and/or	CCONJ
ecj-9105	75	55	epidemiological	epidemiological	ADJ
ecj-9105	75	56	warning	warning	NOUN
ecj-9105	75	57	factors	factor	NOUN
ecj-9105	75	58	,	,	PUNCT
ecj-9105	75	59	performance	performance	NOUN
ecj-9105	75	60	of	of	ADP
ecj-9105	75	61	pcr	pcr	ADJ
ecj-9105	75	62	testing	testing	NOUN
ecj-9105	75	63	for	for	ADP
ecj-9105	75	64	covid-19	covid-19	PROPN
ecj-9105	75	65	it	it	PRON
ecj-9105	75	66	is	be	AUX
ecj-9105	75	67	mandatory	mandatory	ADJ
ecj-9105	75	68	.	.	PUNCT
ecj-9105	76	1	furthermore	furthermore	ADV
ecj-9105	76	2	,	,	PUNCT
ecj-9105	76	3	in	in	ADP
ecj-9105	76	4	our	our	PRON
ecj-9105	76	5	experience	experience	NOUN
ecj-9105	76	6	,	,	PUNCT
ecj-9105	76	7	the	the	DET
ecj-9105	76	8	effects	effect	NOUN
ecj-9105	76	9	related	relate	VERB
ecj-9105	76	10	to	to	ADP
ecj-9105	76	11	covid-19	covid-19	PROPN
ecj-9105	76	12	infection	infection	NOUN
ecj-9105	76	13	on	on	ADP
ecj-9105	76	14	the	the	DET
ecj-9105	76	15	immune	immune	ADJ
ecj-9105	76	16	system	system	NOUN
ecj-9105	76	17	as	as	ADP
ecj-9105	76	18	a	a	DET
ecj-9105	76	19	risk	risk	NOUN
ecj-9105	76	20	factor	factor	NOUN
ecj-9105	76	21	in	in	ADP
ecj-9105	76	22	promoting	promote	VERB
ecj-9105	76	23	bacterial	bacterial	ADJ
ecj-9105	76	24	infection	infection	NOUN
ecj-9105	76	25	appears	appear	VERB
ecj-9105	76	26	to	to	PART
ecj-9105	76	27	be	be	AUX
ecj-9105	76	28	the	the	DET
ecj-9105	76	29	key	key	ADJ
ecj-9105	76	30	message	message	NOUN
ecj-9105	76	31	for	for	ADP
ecj-9105	76	32	those	those	PRON
ecj-9105	76	33	working	work	VERB
ecj-9105	76	34	in	in	ADP
ecj-9105	76	35	emergency	emergency	NOUN
ecj-9105	76	36	departments	department	NOUN
ecj-9105	76	37	.	.	PUNCT
ecj-9105	77	1	therefore	therefore	ADV
ecj-9105	77	2	,	,	PUNCT
ecj-9105	77	3	in	in	ADP
ecj-9105	77	4	the	the	DET
ecj-9105	77	5	presence	presence	NOUN
ecj-9105	77	6	of	of	ADP
ecj-9105	77	7	a	a	DET
ecj-9105	77	8	septic	septic	ADJ
ecj-9105	77	9	appearance	appearance	NOUN
ecj-9105	77	10	and	and	CCONJ
ecj-9105	77	11	elevated	elevated	ADJ
ecj-9105	77	12	inflammatory	inflammatory	ADJ
ecj-9105	77	13	indexes	index	NOUN
ecj-9105	77	14	of	of	ADP
ecj-9105	77	15	a	a	DET
ecj-9105	77	16	patient	patient	NOUN
ecj-9105	77	17	,	,	PUNCT
ecj-9105	77	18	searching	search	VERB
ecj-9105	77	19	for	for	ADP
ecj-9105	77	20	other	other	ADJ
ecj-9105	77	21	aetiologies	aetiology	NOUN
ecj-9105	77	22	remains	remain	VERB
ecj-9105	77	23	fundamental	fundamental	ADJ
ecj-9105	77	24	in	in	ADP
ecj-9105	77	25	clinical	clinical	ADJ
ecj-9105	77	26	practice	practice	NOUN
ecj-9105	77	27	.	.	PUNCT
ecj-9105	78	1	finally	finally	ADV
ecj-9105	78	2	,	,	PUNCT
ecj-9105	78	3	this	this	DET
ecj-9105	78	4	case	case	NOUN
ecj-9105	78	5	highlights	highlight	VERB
ecj-9105	78	6	a	a	DET
ecj-9105	78	7	likelihood	likelihood	NOUN
ecj-9105	78	8	of	of	ADP
ecj-9105	78	9	poor	poor	ADJ
ecj-9105	78	10	performance	performance	NOUN
ecj-9105	78	11	of	of	ADP
ecj-9105	78	12	current	current	ADJ
ecj-9105	78	13	case	case	NOUN
ecj-9105	78	14	definitions	definition	NOUN
ecj-9105	78	15	used	use	VERB
ecj-9105	78	16	to	to	PART
ecj-9105	78	17	contain	contain	VERB
ecj-9105	78	18	covid-19	covid-19	PROPN
ecj-9105	78	19	,	,	PUNCT
ecj-9105	78	20	mainly	mainly	ADV
ecj-9105	78	21	in	in	ADP
ecj-9105	78	22	infants	infant	NOUN
ecj-9105	78	23	.	.	PUNCT
ecj-9105	79	1	there	there	PRON
ecj-9105	79	2	is	be	VERB
ecj-9105	79	3	an	an	DET
ecj-9105	79	4	urgent	urgent	ADJ
ecj-9105	79	5	need	need	NOUN
ecj-9105	79	6	to	to	PART
ecj-9105	79	7	better	well	ADV
ecj-9105	79	8	understand	understand	VERB
ecj-9105	79	9	the	the	DET
ecj-9105	79	10	full	full	ADJ
ecj-9105	79	11	clinical	clinical	ADJ
ecj-9105	79	12	spectrum	spectrum	NOUN
ecj-9105	79	13	of	of	ADP
ecj-9105	79	14	covid-19	covid-19	PROPN
ecj-9105	79	15	in	in	ADP
ecj-9105	79	16	the	the	DET
ecj-9105	79	17	pediatric	pediatric	ADJ
ecj-9105	79	18	population	population	NOUN
ecj-9105	79	19	in	in	ADP
ecj-9105	79	20	order	order	NOUN
ecj-9105	79	21	to	to	PART
ecj-9105	79	22	refine	refine	VERB
ecj-9105	79	23	public	public	ADJ
ecj-9105	79	24	health	health	NOUN
ecj-9105	79	25	containment	containment	NOUN
ecj-9105	79	26	strategies	strategy	NOUN
ecj-9105	79	27	.	.	PUNCT
ecj-9105	80	1	references	reference	NOUN
ecj-9105	80	2	1	1	NUM
ecj-9105	80	3	.	.	PUNCT
ecj-9105	80	4	remuzzi	remuzzi	VERB
ecj-9105	80	5	a	a	PRON
ecj-9105	80	6	,	,	PUNCT
ecj-9105	80	7	remuzzi	remuzzi	NOUN
ecj-9105	80	8	g.	g.	PROPN
ecj-9105	80	9	covid-19	covid-19	PROPN
ecj-9105	80	10	and	and	CCONJ
ecj-9105	80	11	italy	italy	PROPN
ecj-9105	80	12	:	:	PUNCT
ecj-9105	80	13	what	what	PRON
ecj-9105	80	14	next	next	ADV
ecj-9105	80	15	?	?	PUNCT
ecj-9105	81	1	lancet	lancet	PROPN
ecj-9105	81	2	2020;395:1225	2020;395:1225	NUM
ecj-9105	81	3	-	-	SYM
ecj-9105	81	4	8	8	NUM
ecj-9105	81	5	.	.	NOUN
ecj-9105	81	6	2	2	NUM
ecj-9105	81	7	.	.	X
ecj-9105	81	8	zhang	zhang	PROPN
ecj-9105	82	1	yh	yh	PROPN
ecj-9105	82	2	,	,	PUNCT
ecj-9105	82	3	lin	lin	PROPN
ecj-9105	82	4	dj	dj	PROPN
ecj-9105	82	5	,	,	PUNCT
ecj-9105	82	6	xiao	xiao	PROPN
ecj-9105	82	7	mf	mf	PROPN
ecj-9105	82	8	,	,	PUNCT
ecj-9105	82	9	et	et	PROPN
ecj-9105	82	10	al	al	PROPN
ecj-9105	82	11	.	.	PUNCT
ecj-9105	83	1	[	[	X
ecj-9105	83	2	2019	2019	NUM
ecj-9105	83	3	novel	novel	ADJ
ecj-9105	83	4	coronavirus	coronavirus	NOUN
ecj-9105	83	5	infection	infection	NOUN
ecj-9105	83	6	in	in	ADP
ecj-9105	83	7	a	a	DET
ecj-9105	83	8	three	three	NUM
ecj-9105	83	9	-	-	PUNCT
ecj-9105	83	10	month	month	NOUN
ecj-9105	83	11	-	-	PUNCT
ecj-9105	83	12	old	old	ADJ
ecj-9105	83	13	baby	baby	NOUN
ecj-9105	83	14	]	]	PUNCT
ecj-9105	83	15	.	.	PUNCT
ecj-9105	84	1	zhonghua	zhonghua	PROPN
ecj-9105	84	2	er	er	INTJ
ecj-9105	84	3	ke	ke	PROPN
ecj-9105	84	4	za	za	PROPN
ecj-9105	84	5	zhi	zhi	PROPN
ecj-9105	84	6	2020;58:182	2020;58:182	NOUN
ecj-9105	84	7	-	-	PUNCT
ecj-9105	84	8	4	4	NUM
ecj-9105	84	9	.	.	PUNCT
ecj-9105	85	1	[	[	X
ecj-9105	85	2	article	article	NOUN
ecj-9105	85	3	in	in	ADP
ecj-9105	85	4	chinese	chinese	PROPN
ecj-9105	85	5	]	]	PUNCT
ecj-9105	85	6	.	.	PUNCT
ecj-9105	86	1	3	3	X
ecj-9105	86	2	.	.	X
ecj-9105	87	1	yonker	yonker	PROPN
ecj-9105	87	2	lm	lm	PROPN
ecj-9105	87	3	,	,	PUNCT
ecj-9105	87	4	neilan	neilan	NOUN
ecj-9105	87	5	am	be	AUX
ecj-9105	87	6	,	,	PUNCT
ecj-9105	87	7	bartsch	bartsch	VERB
ecj-9105	87	8	y	y	PRON
ecj-9105	87	9	,	,	PUNCT
ecj-9105	87	10	et	et	PROPN
ecj-9105	87	11	al	al	PROPN
ecj-9105	87	12	.	.	PROPN
ecj-9105	88	1	pediatric	pediatric	ADJ
ecj-9105	88	2	severe	severe	ADJ
ecj-9105	88	3	acute	acute	ADJ
ecj-9105	88	4	respiratory	respiratory	ADJ
ecj-9105	88	5	syndrome	syndrome	NOUN
ecj-9105	88	6	coronavirus	coronavirus	NOUN
ecj-9105	88	7	2	2	NUM
ecj-9105	88	8	(	(	PUNCT
ecj-9105	88	9	sars	sar	NOUN
ecj-9105	88	10	-	-	PUNCT
ecj-9105	88	11	cov-2	cov-2	NOUN
ecj-9105	88	12	):	):	PUNCT
ecj-9105	88	13	clinical	clinical	ADJ
ecj-9105	88	14	presentation	presentation	NOUN
ecj-9105	88	15	,	,	PUNCT
ecj-9105	88	16	infectivity	infectivity	NOUN
ecj-9105	88	17	,	,	PUNCT
ecj-9105	88	18	and	and	CCONJ
ecj-9105	88	19	immune	immune	ADJ
ecj-9105	88	20	responses	response	NOUN
ecj-9105	88	21	.	.	PUNCT
ecj-9105	89	1	j	j	PROPN
ecj-9105	89	2	pediatr	pediatr	PROPN
ecj-9105	89	3	2020;227:45	2020;227:45	ADV
ecj-9105	89	4	-	-	SYM
ecj-9105	89	5	52.e5	52.e5	NUM
ecj-9105	89	6	.	.	NOUN
ecj-9105	89	7	4	4	NUM
ecj-9105	89	8	.	.	X
ecj-9105	89	9	diao	diao	PROPN
ecj-9105	89	10	b	b	PROPN
ecj-9105	89	11	,	,	PUNCT
ecj-9105	89	12	wang	wang	PROPN
ecj-9105	89	13	c	c	PROPN
ecj-9105	89	14	,	,	PUNCT
ecj-9105	89	15	tan	tan	PROPN
ecj-9105	89	16	y	y	PROPN
ecj-9105	89	17	,	,	PUNCT
ecj-9105	89	18	et	et	PROPN
ecj-9105	89	19	al	al	PROPN
ecj-9105	89	20	.	.	PUNCT
ecj-9105	89	21	reduction	reduction	NOUN
ecj-9105	89	22	and	and	CCONJ
ecj-9105	89	23	functional	functional	ADJ
ecj-9105	89	24	exhaustion	exhaustion	NOUN
ecj-9105	89	25	of	of	ADP
ecj-9105	89	26	t	t	NOUN
ecj-9105	89	27	cells	cell	NOUN
ecj-9105	89	28	in	in	ADP
ecj-9105	89	29	patients	patient	NOUN
ecj-9105	89	30	with	with	ADP
ecj-9105	89	31	coronavirus	coronavirus	NOUN
ecj-9105	89	32	disease	disease	NOUN
ecj-9105	89	33	2019	2019	NUM
ecj-9105	89	34	(	(	PUNCT
ecj-9105	89	35	covid-19	covid-19	PROPN
ecj-9105	89	36	)	)	PUNCT
ecj-9105	89	37	.	.	PUNCT
ecj-9105	90	1	front	front	ADJ
ecj-9105	90	2	immunol	immunol	NOUN
ecj-9105	90	3	2020;11:827	2020;11:827	NOUN
ecj-9105	90	4	.	.	PUNCT
ecj-9105	91	1	5	5	NUM
ecj-9105	91	2	.	.	PUNCT
ecj-9105	91	3	yaqinuddin	yaqinuddin	VERB
ecj-9105	91	4	a	a	DET
ecj-9105	91	5	,	,	PUNCT
ecj-9105	91	6	kashir	kashir	PROPN
ecj-9105	91	7	j.	j.	PROPN
ecj-9105	91	8	innate	innate	PROPN
ecj-9105	91	9	immunity	immunity	NOUN
ecj-9105	91	10	in	in	ADP
ecj-9105	91	11	covid-19	covid-19	PROPN
ecj-9105	91	12	patients	patient	NOUN
ecj-9105	91	13	mediated	mediate	VERB
ecj-9105	91	14	by	by	ADP
ecj-9105	91	15	nkg2a	nkg2a	NOUN
ecj-9105	91	16	receptors	receptor	NOUN
ecj-9105	91	17	,	,	PUNCT
ecj-9105	91	18	and	and	CCONJ
ecj-9105	91	19	potential	potential	ADJ
ecj-9105	91	20	treatment	treatment	NOUN
ecj-9105	91	21	using	use	VERB
ecj-9105	91	22	monalizumab	monalizumab	NOUN
ecj-9105	91	23	,	,	PUNCT
ecj-9105	91	24	cholroquine	cholroquine	ADJ
ecj-9105	91	25	,	,	PUNCT
ecj-9105	91	26	and	and	CCONJ
ecj-9105	91	27	antiviral	antiviral	ADJ
ecj-9105	91	28	agents	agent	NOUN
ecj-9105	91	29	.	.	PUNCT
ecj-9105	92	1	med	med	ADJ
ecj-9105	92	2	hypotheses	hypothesis	NOUN
ecj-9105	92	3	2020;140:109777	2020;140:109777	NUM
ecj-9105	92	4	.	.	PUNCT
ecj-9105	93	1	6	6	NUM
ecj-9105	93	2	.	.	X
ecj-9105	94	1	who	who	PRON
ecj-9105	94	2	.	.	PUNCT
ecj-9105	95	1	updated	update	VERB
ecj-9105	95	2	who	who	PRON
ecj-9105	95	3	recommendations	recommendation	VERB
ecj-9105	95	4	for	for	ADP
ecj-9105	95	5	international	international	ADJ
ecj-9105	95	6	traffic	traffic	NOUN
ecj-9105	95	7	in	in	ADP
ecj-9105	95	8	relation	relation	NOUN
ecj-9105	95	9	to	to	ADP
ecj-9105	95	10	covid-19	covid-19	PROPN
ecj-9105	95	11	outbreak	outbreak	NOUN
ecj-9105	95	12	.	.	PUNCT
ecj-9105	96	1	available	available	ADJ
ecj-9105	96	2	at	at	ADP
ecj-9105	96	3	:	:	PUNCT
ecj-9105	96	4	https://www.who.int/news-room/articles-detail/updated-whorecommendations-for-international-traffic-in-relation-tocovid-19-outbreak	https://www.who.int/news-room/articles-detail/updated-whorecommendations-for-international-traffic-in-relation-tocovid-19-outbreak	NOUN
ecj-9105	96	5	7	7	NUM
ecj-9105	96	6	.	.	X
ecj-9105	96	7	weiss	weiss	PROPN
ecj-9105	96	8	sl	sl	PROPN
ecj-9105	96	9	,	,	PUNCT
ecj-9105	96	10	peters	peters	PROPN
ecj-9105	96	11	mj	mj	PROPN
ecj-9105	96	12	,	,	PUNCT
ecj-9105	96	13	alhazzani	alhazzani	PROPN
ecj-9105	96	14	w	w	PROPN
ecj-9105	96	15	,	,	PUNCT
ecj-9105	96	16	et	et	PROPN
ecj-9105	96	17	al	al	PROPN
ecj-9105	96	18	.	.	PUNCT
ecj-9105	97	1	surviving	survive	VERB
ecj-9105	97	2	sepsis	sepsis	NOUN
ecj-9105	97	3	campaign	campaign	NOUN
ecj-9105	97	4	international	international	ADJ
ecj-9105	97	5	guidelines	guideline	NOUN
ecj-9105	97	6	for	for	ADP
ecj-9105	97	7	the	the	DET
ecj-9105	97	8	management	management	NOUN
ecj-9105	97	9	of	of	ADP
ecj-9105	97	10	septic	septic	ADJ
ecj-9105	97	11	shock	shock	NOUN
ecj-9105	97	12	and	and	CCONJ
ecj-9105	97	13	sepsis	sepsis	NOUN
ecj-9105	97	14	-	-	PUNCT
ecj-9105	97	15	associated	associate	VERB
ecj-9105	97	16	organ	organ	NOUN
ecj-9105	97	17	dysfunction	dysfunction	NOUN
ecj-9105	97	18	in	in	ADP
ecj-9105	97	19	children	child	NOUN
ecj-9105	97	20	.	.	PUNCT
ecj-9105	98	1	pediatr	pediatr	PROPN
ecj-9105	98	2	crit	crit	PROPN
ecj-9105	98	3	care	care	PROPN
ecj-9105	98	4	med	med	PROPN
ecj-9105	98	5	2020;21	2020;21	PROPN
ecj-9105	98	6	:	:	PUNCT
ecj-9105	98	7	e52	e52	PROPN
ecj-9105	98	8	-	-	PUNCT
ecj-9105	98	9	e106	e106	PROPN
ecj-9105	98	10	.	.	PROPN
ecj-9105	99	1	8	8	NUM
ecj-9105	99	2	.	.	PUNCT
ecj-9105	100	1	chen	chen	PROPN
ecj-9105	100	2	zm	zm	PROPN
ecj-9105	100	3	,	,	PUNCT
ecj-9105	100	4	fu	fu	PROPN
ecj-9105	100	5	jf	jf	PROPN
ecj-9105	100	6	,	,	PUNCT
ecj-9105	100	7	shu	shu	PROPN
ecj-9105	100	8	q.	q.	PROPN
ecj-9105	100	9	new	new	PROPN
ecj-9105	100	10	coronavirus	coronavirus	PROPN
ecj-9105	100	11	:	:	PUNCT
ecj-9105	100	12	new	new	ADJ
ecj-9105	100	13	challenges	challenge	NOUN
ecj-9105	100	14	for	for	ADP
ecj-9105	100	15	pediatricians	pediatrician	NOUN
ecj-9105	100	16	.	.	PUNCT
ecj-9105	101	1	world	world	PROPN
ecj-9105	101	2	j	j	PROPN
ecj-9105	101	3	pediatr	pediatr	PROPN
ecj-9105	101	4	2020;16:222	2020;16:222	PROPN
ecj-9105	101	5	.	.	PUNCT
ecj-9105	102	1	9	9	NUM
ecj-9105	102	2	.	.	X
ecj-9105	102	3	sun	sun	PROPN
ecj-9105	102	4	d	d	PROPN
ecj-9105	102	5	,	,	PUNCT
ecj-9105	102	6	li	li	PROPN
ecj-9105	102	7	h	h	PROPN
ecj-9105	102	8	,	,	PUNCT
ecj-9105	102	9	lu	lu	PROPN
ecj-9105	102	10	x	x	NOUN
ecj-9105	102	11	,	,	PUNCT
ecj-9105	102	12	et	et	PROPN
ecj-9105	102	13	al	al	PROPN
ecj-9105	102	14	.	.	PUNCT
ecj-9105	103	1	clinical	clinical	ADJ
ecj-9105	103	2	features	feature	NOUN
ecj-9105	103	3	of	of	ADP
ecj-9105	103	4	severe	severe	ADJ
ecj-9105	103	5	pediatric	pediatric	ADJ
ecj-9105	103	6	patients	patient	NOUN
ecj-9105	103	7	with	with	ADP
ecj-9105	103	8	coronavirus	coronavirus	NOUN
ecj-9105	103	9	disease	disease	NOUN
ecj-9105	103	10	2019	2019	NUM
ecj-9105	103	11	in	in	ADP
ecj-9105	103	12	wuhan	wuhan	PROPN
ecj-9105	103	13	:	:	PUNCT
ecj-9105	103	14	a	a	DET
ecj-9105	103	15	single	single	ADJ
ecj-9105	103	16	center	center	NOUN
ecj-9105	103	17	’s	’s	PART
ecj-9105	103	18	observational	observational	ADJ
ecj-9105	103	19	study	study	NOUN
ecj-9105	103	20	.	.	PUNCT
ecj-9105	104	1	world	world	PROPN
ecj-9105	104	2	j	j	PROPN
ecj-9105	104	3	pediatr	pediatr	PROPN
ecj-9105	104	4	2020;16:251	2020;16:251	PROPN
ecj-9105	104	5	-	-	SYM
ecj-9105	104	6	9	9	NUM
ecj-9105	104	7	.	.	NOUN
ecj-9105	104	8	10	10	NUM
ecj-9105	104	9	.	.	PUNCT
ecj-9105	105	1	cai	cai	PROPN
ecj-9105	105	2	jh	jh	PROPN
ecj-9105	105	3	,	,	PUNCT
ecj-9105	105	4	wang	wang	PROPN
ecj-9105	105	5	xs	xs	PROPN
ecj-9105	105	6	,	,	PUNCT
ecj-9105	105	7	ge	ge	PROPN
ecj-9105	105	8	yl	yl	PROPN
ecj-9105	105	9	,	,	PUNCT
ecj-9105	105	10	et	et	PROPN
ecj-9105	105	11	al	al	PROPN
ecj-9105	105	12	.	.	PUNCT
ecj-9105	106	1	[	[	X
ecj-9105	106	2	first	first	ADJ
ecj-9105	106	3	case	case	NOUN
ecj-9105	106	4	of	of	ADP
ecj-9105	106	5	2019	2019	NUM
ecj-9105	106	6	novel	novel	ADJ
ecj-9105	106	7	coronavirus	coronavirus	NOUN
ecj-9105	106	8	infection	infection	NOUN
ecj-9105	106	9	in	in	ADP
ecj-9105	106	10	children	child	NOUN
ecj-9105	106	11	in	in	ADP
ecj-9105	106	12	shanghai	shanghai	PROPN
ecj-9105	106	13	]	]	PUNCT
ecj-9105	106	14	.	.	PUNCT
ecj-9105	107	1	zhonghua	zhonghua	PROPN
ecj-9105	107	2	er	er	INTJ
ecj-9105	107	3	ke	ke	PROPN
ecj-9105	107	4	za	za	PROPN
ecj-9105	107	5	zhi	zhi	PROPN
ecj-9105	107	6	2020;58	2020;58	NUM
ecj-9105	107	7	:	:	PUNCT
ecj-9105	107	8	e002	e002	NUM
ecj-9105	107	9	.	.	PUNCT
ecj-9105	108	1	[	[	X
ecj-9105	108	2	article	article	NOUN
ecj-9105	108	3	in	in	ADP
ecj-9105	108	4	chinese	chinese	PROPN
ecj-9105	108	5	]	]	PUNCT
ecj-9105	108	6	.	.	PUNCT
ecj-9105	109	1	11	11	NUM
ecj-9105	109	2	.	.	PUNCT
ecj-9105	110	1	cai	cai	PROPN
ecj-9105	110	2	j	j	PROPN
ecj-9105	110	3	,	,	PUNCT
ecj-9105	110	4	xu	xu	PROPN
ecj-9105	110	5	j	j	PROPN
ecj-9105	110	6	,	,	PUNCT
ecj-9105	110	7	lin	lin	PROPN
ecj-9105	110	8	d	d	PROPN
ecj-9105	110	9	,	,	PUNCT
ecj-9105	110	10	et	et	PROPN
ecj-9105	110	11	al	al	PROPN
ecj-9105	110	12	.	.	PUNCT
ecj-9105	111	1	a	a	DET
ecj-9105	111	2	case	case	NOUN
ecj-9105	111	3	series	series	NOUN
ecj-9105	111	4	of	of	ADP
ecj-9105	111	5	children	child	NOUN
ecj-9105	111	6	with	with	ADP
ecj-9105	111	7	2019	2019	NUM
ecj-9105	111	8	novel	novel	ADJ
ecj-9105	111	9	coronavirus	coronavirus	NOUN
ecj-9105	111	10	infection	infection	NOUN
ecj-9105	111	11	:	:	PUNCT
ecj-9105	111	12	clinical	clinical	ADJ
ecj-9105	111	13	and	and	CCONJ
ecj-9105	111	14	epidemiological	epidemiological	ADJ
ecj-9105	111	15	features	feature	NOUN
ecj-9105	111	16	.	.	PUNCT
ecj-9105	112	1	clin	clin	PROPN
ecj-9105	112	2	infect	infect	PROPN
ecj-9105	112	3	dis	dis	PROPN
ecj-9105	112	4	2020;71:1547	2020;71:1547	PROPN
ecj-9105	112	5	-	-	SYM
ecj-9105	112	6	51	51	NUM
ecj-9105	112	7	.	.	PUNCT
ecj-9105	112	8	12	12	NUM
ecj-9105	112	9	.	.	PUNCT
ecj-9105	113	1	li	li	PROPN
ecj-9105	113	2	h	h	PROPN
ecj-9105	113	3	,	,	PUNCT
ecj-9105	113	4	liu	liu	PROPN
ecj-9105	113	5	l	l	PROPN
ecj-9105	113	6	,	,	PUNCT
ecj-9105	114	1	zhang	zhang	PROPN
ecj-9105	114	2	d	d	PROPN
ecj-9105	114	3	,	,	PUNCT
ecj-9105	114	4	et	et	PROPN
ecj-9105	114	5	al	al	PROPN
ecj-9105	114	6	.	.	PUNCT
ecj-9105	115	1	sars	sars	PROPN
ecj-9105	115	2	-	-	PUNCT
ecj-9105	115	3	cov-2	cov-2	NUM
ecj-9105	115	4	and	and	CCONJ
ecj-9105	115	5	viral	viral	ADJ
ecj-9105	115	6	sepsis	sepsis	NOUN
ecj-9105	115	7	:	:	PUNCT
ecj-9105	115	8	observations	observation	NOUN
ecj-9105	115	9	and	and	CCONJ
ecj-9105	115	10	hypotheses	hypothesis	NOUN
ecj-9105	115	11	.	.	PUNCT
ecj-9105	116	1	lancet	lancet	PROPN
ecj-9105	116	2	2020;395:1517	2020;395:1517	NUM
ecj-9105	116	3	-	-	SYM
ecj-9105	116	4	20	20	NUM
ecj-9105	116	5	.	.	PUNCT
ecj-9105	116	6	13	13	NUM
ecj-9105	116	7	.	.	PUNCT
ecj-9105	117	1	huang	huang	PROPN
ecj-9105	117	2	c	c	PROPN
ecj-9105	117	3	,	,	PUNCT
ecj-9105	117	4	wang	wang	PROPN
ecj-9105	117	5	y	y	PROPN
ecj-9105	117	6	,	,	PUNCT
ecj-9105	117	7	li	li	PROPN
ecj-9105	117	8	x	x	PROPN
ecj-9105	117	9	,	,	PUNCT
ecj-9105	117	10	et	et	PROPN
ecj-9105	117	11	al	al	PROPN
ecj-9105	117	12	.	.	PUNCT
ecj-9105	118	1	clinical	clinical	ADJ
ecj-9105	118	2	features	feature	NOUN
ecj-9105	118	3	of	of	ADP
ecj-9105	118	4	patients	patient	NOUN
ecj-9105	118	5	infected	infect	VERB
ecj-9105	118	6	with	with	ADP
ecj-9105	118	7	2019	2019	NUM
ecj-9105	118	8	novel	novel	ADJ
ecj-9105	118	9	coronavirus	coronavirus	NOUN
ecj-9105	118	10	in	in	ADP
ecj-9105	118	11	wuhan	wuhan	PROPN
ecj-9105	118	12	,	,	PUNCT
ecj-9105	118	13	china	china	PROPN
ecj-9105	118	14	.	.	PUNCT
ecj-9105	119	1	lancet	lancet	PROPN
ecj-9105	119	2	2020;395:497	2020;395:497	PROPN
ecj-9105	119	3	-	-	SYM
ecj-9105	119	4	506	506	NUM
ecj-9105	119	5	.	.	PUNCT
ecj-9105	119	6	14	14	NUM
ecj-9105	119	7	.	.	PUNCT
ecj-9105	120	1	jones	jones	PROPN
ecj-9105	120	2	sa	sa	PROPN
ecj-9105	120	3	,	,	PUNCT
ecj-9105	120	4	jenkins	jenkins	PROPN
ecj-9105	120	5	bj	bj	VERB
ecj-9105	120	6	.	.	PUNCT
ecj-9105	121	1	recent	recent	ADJ
ecj-9105	121	2	insights	insight	NOUN
ecj-9105	121	3	into	into	ADP
ecj-9105	121	4	targeting	target	VERB
ecj-9105	121	5	the	the	DET
ecj-9105	121	6	il-6	il-6	NUM
ecj-9105	121	7	cytokine	cytokine	ADJ
ecj-9105	121	8	family	family	NOUN
ecj-9105	121	9	in	in	ADP
ecj-9105	121	10	inflammatory	inflammatory	ADJ
ecj-9105	121	11	diseases	disease	NOUN
ecj-9105	121	12	and	and	CCONJ
ecj-9105	121	13	cancer	cancer	NOUN
ecj-9105	121	14	.	.	PUNCT
ecj-9105	122	1	nat	nat	PROPN
ecj-9105	122	2	rev	rev	VERB
ecj-9105	122	3	immunol	immunol	PROPN
ecj-9105	122	4	2018;18:773	2018;18:773	PROPN
ecj-9105	122	5	-	-	SYM
ecj-9105	122	6	89	89	NUM
ecj-9105	122	7	.	.	PUNCT
ecj-9105	122	8	15	15	NUM
ecj-9105	122	9	.	.	X
ecj-9105	123	1	fielding	field	VERB
ecj-9105	123	2	ca	ca	PROPN
ecj-9105	123	3	,	,	PUNCT
ecj-9105	123	4	jones	jones	PROPN
ecj-9105	123	5	gw	gw	PROPN
ecj-9105	123	6	,	,	PUNCT
ecj-9105	123	7	mcloughlin	mcloughlin	PROPN
ecj-9105	123	8	rm	rm	PROPN
ecj-9105	123	9	,	,	PUNCT
ecj-9105	123	10	et	et	PROPN
ecj-9105	123	11	al	al	PROPN
ecj-9105	123	12	.	.	PROPN
ecj-9105	124	1	interleukin-6	interleukin-6	PRON
ecj-9105	124	2	signaling	signal	VERB
ecj-9105	124	3	drives	drive	NOUN
ecj-9105	124	4	fibrosis	fibrosis	NOUN
ecj-9105	124	5	in	in	ADP
ecj-9105	124	6	unresolved	unresolved	ADJ
ecj-9105	124	7	inflammation	inflammation	NOUN
ecj-9105	124	8	.	.	PUNCT
ecj-9105	125	1	immunity	immunity	NOUN
ecj-9105	125	2	2014;40:40	2014;40:40	NUM
ecj-9105	125	3	-	-	SYM
ecj-9105	125	4	50	50	NUM
ecj-9105	125	5	.	.	PUNCT
ecj-9105	125	6	16	16	NUM
ecj-9105	125	7	.	.	PUNCT
ecj-9105	126	1	chuang	chuang	PROPN
ecj-9105	126	2	ch	ch	PROPN
ecj-9105	126	3	,	,	PUNCT
ecj-9105	126	4	janapatla	janapatla	NOUN
ecj-9105	126	5	rp	rp	NOUN
ecj-9105	126	6	,	,	PUNCT
ecj-9105	126	7	wang	wang	PROPN
ecj-9105	126	8	yh	yh	PROPN
ecj-9105	126	9	,	,	PUNCT
ecj-9105	126	10	et	et	PROPN
ecj-9105	126	11	al	al	PROPN
ecj-9105	126	12	.	.	PROPN
ecj-9105	127	1	pseudomonas	pseudomona	VERB
ecj-9105	127	2	aeruginosa	aeruginosa	NOUN
ecj-9105	127	3	-	-	PUNCT
ecj-9105	127	4	associated	associate	VERB
ecj-9105	127	5	diarrheal	diarrheal	NOUN
ecj-9105	127	6	diseases	disease	NOUN
ecj-9105	127	7	in	in	ADP
ecj-9105	127	8	children	child	NOUN
ecj-9105	127	9	.	.	PUNCT
ecj-9105	128	1	pediatr	pediatr	PROPN
ecj-9105	128	2	infect	infect	VERB
ecj-9105	128	3	dis	dis	PROPN
ecj-9105	128	4	j	j	PROPN
ecj-9105	128	5	2017;36:1119	2017;36:1119	PROPN
ecj-9105	128	6	-	-	SYM
ecj-9105	128	7	23	23	NUM
ecj-9105	128	8	.	.	PUNCT
ecj-9105	129	1	17	17	NUM
ecj-9105	129	2	.	.	PUNCT
ecj-9105	130	1	coronado	coronado	PROPN
ecj-9105	130	2	munoz	munoz	PROPN
ecj-9105	130	3	a	a	PRON
ecj-9105	130	4	,	,	PUNCT
ecj-9105	130	5	nawaratne	nawaratne	PROPN
ecj-9105	130	6	u	u	PROPN
ecj-9105	130	7	,	,	PUNCT
ecj-9105	130	8	mcmann	mcmann	PROPN
ecj-9105	130	9	d	d	PROPN
ecj-9105	130	10	,	,	PUNCT
ecj-9105	130	11	et	et	PROPN
ecj-9105	130	12	al	al	PROPN
ecj-9105	130	13	.	.	PROPN
ecj-9105	130	14	lateonset	lateonset	PROPN
ecj-9105	131	1	neonatal	neonatal	ADJ
ecj-9105	131	2	sepsis	sepsis	NOUN
ecj-9105	131	3	in	in	ADP
ecj-9105	131	4	a	a	DET
ecj-9105	131	5	patient	patient	NOUN
ecj-9105	131	6	with	with	ADP
ecj-9105	131	7	covid-19	covid-19	PROPN
ecj-9105	131	8	.	.	PUNCT
ecj-9105	132	1	n	n	PROPN
ecj-9105	132	2	engl	engl	PROPN
ecj-9105	132	3	j	j	PROPN
ecj-9105	132	4	med	med	PROPN
ecj-9105	132	5	2020;382	2020;382	NUM
ecj-9105	132	6	:	:	PUNCT
ecj-9105	132	7	e49	e49	PROPN
ecj-9105	132	8	.	.	PUNCT
ecj-9105	133	1	18	18	NUM
ecj-9105	133	2	.	.	PUNCT
ecj-9105	133	3	kamali	kamali	PROPN
ecj-9105	133	4	aghdam	aghdam	PROPN
ecj-9105	133	5	m	m	PROPN
ecj-9105	133	6	,	,	PUNCT
ecj-9105	133	7	jafari	jafari	PROPN
ecj-9105	133	8	n	n	CCONJ
ecj-9105	133	9	,	,	PUNCT
ecj-9105	133	10	eftekhari	eftekhari	PROPN
ecj-9105	133	11	k.	k.	PROPN
ecj-9105	133	12	novel	novel	PROPN
ecj-9105	133	13	coronavirus	coronavirus	NOUN
ecj-9105	133	14	in	in	ADP
ecj-9105	133	15	a	a	DET
ecj-9105	133	16	15	15	NUM
ecj-9105	133	17	-	-	PUNCT
ecj-9105	133	18	day	day	NOUN
ecj-9105	133	19	-	-	PUNCT
ecj-9105	133	20	old	old	ADJ
ecj-9105	133	21	neonate	neonate	NOUN
ecj-9105	133	22	with	with	ADP
ecj-9105	133	23	clinical	clinical	ADJ
ecj-9105	133	24	signs	sign	NOUN
ecj-9105	133	25	of	of	ADP
ecj-9105	133	26	sepsis	sepsis	NOUN
ecj-9105	133	27	,	,	PUNCT
ecj-9105	133	28	a	a	DET
ecj-9105	133	29	case	case	NOUN
ecj-9105	133	30	report	report	NOUN
ecj-9105	133	31	.	.	PUNCT
ecj-9105	134	1	infect	infect	VERB
ecj-9105	134	2	dis	dis	PROPN
ecj-9105	134	3	(	(	PUNCT
ecj-9105	134	4	lond	lond	ADJ
ecj-9105	134	5	)	)	PUNCT
ecj-9105	134	6	2020;52:427	2020;52:427	PROPN
ecj-9105	134	7	-	-	SYM
ecj-9105	134	8	9	9	NUM
ecj-9105	134	9	.	.	PUNCT
ecj-9105	134	10	case	case	NOUN
ecj-9105	134	11	report	report	VERB
ecj-9105	134	12	non	non	ADJ
ecj-9105	134	13	-co	-co	PROPN
ecj-9105	134	14	mmerc	mmerc	PROPN
ecj-9105	134	15	ial	ial	PROPN
ecj-9105	135	1	us	us	PROPN
ecj-9105	135	2	e	e	NOUN
ecj-9105	135	3	o	o	NOUN
ecj-9105	136	1	nly	nly	ADV